[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 4596
1. Ilić I, Randelović P, Ilić R, Dordević L, Radojković D: [Granular-cell tumor: a rare variant of mammary tumor]. Vojnosanit Pregl; 2008 Jun;65(6):488-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Granular-cell tumor: a rare variant of mammary tumor].
  • BACKGROUND: Granular cell tumor (GCT) is a rare variant of mammary tumor beset with diagnostic dilemmas that may be resolved by using numerous, very complex, enzymohistochemical and immunohistochemical methods.
  • CASE REPORTS: We reported three female patients 16, 21 and 65 years old, operated on for mammary tumor at the Surgical Clinic of the School of Medicine in Nis, over the period of thirty years, 1977 to 2007.
  • During this period 14.022 mammary tumors were diagnosed, including these three cases.
  • These tumors had benign characteristics, without associated tumors in other localizations.
  • The tumors were analyzed by sets of histochemical, enzymohistochemical, immunohistochemical methods as well as ultrastructural examination.
  • The ultrastructural analysis confirmed that the tumor cells were enriched by lysosomes and consequential disorganization of cytoplasm.
  • CONCLUSION: The reported enzymo- and immunohistochemical combined methods provide a precise diagnosis and confirm the GCT's neural origin, which has been disputed for years.
  • [MeSH-major] Breast Neoplasms / pathology. Granular Cell Tumor / pathology

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18672708.001).
  • [ISSN] 0042-8450
  • [Journal-full-title] Vojnosanitetski pregled
  • [ISO-abbreviation] Vojnosanit Pregl
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


2. Marret H, Sauget S, Giraudeau B, Body G, Tranquart F: Power Doppler vascularity index for predicting malignancy of adnexal masses. Ultrasound Obstet Gynecol; 2005 May;25(5):508-13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To assess the performance of a power Doppler vascularity index in the preoperative diagnosis of ovarian malignancy.
  • The tumor vascularity index (power Doppler index, PDI) was determined by quantification of the number of pixels in a defined region of interest according to the formula: number of colored pixels/(total number of pixels minus the number of pixels in the fluid or avascular areas).
  • It was estimated on selected frames of the tumors using an in-house color-quantifying program added to MATLAB 6.0 software.
  • A subjective visual score of power Doppler signals in the tumor was used to classify it as having low, moderate or high vascularity.
  • RESULTS: Histology identified 23 malignant and 78 benign lesions.
  • The PDI was considerably higher in malignant than in benign lesions (0.34 +/- 0.04 vs. 0.12 +/- 0.06; P < 0.001).
  • The PDI cut-off value to differentiate malignant from benign tumors was set at 0.265 (26.5% of the tumor being colored).
  • Logistic regression demonstrated that PDI was the best parameter for differentiating between malignant and benign tumors.
  • CONCLUSION: The power Doppler vascularity index obtained using customized color quantifying software has high diagnostic value in discriminating between benign and malignant adnexal masses.
  • [MeSH-major] Adnexa Uteri / ultrasonography. Adnexal Diseases / ultrasonography. Ovarian Neoplasms / ultrasonography. Ultrasonography, Doppler / methods
  • [MeSH-minor] Adult. Aged. Chi-Square Distribution. Diagnosis, Differential. Female. Humans. Middle Aged. Ovary / physiopathology. Ovary / ultrasonography. Pilot Projects. Prospective Studies. ROC Curve. Regional Blood Flow. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15846763.001).
  • [ISSN] 0960-7692
  • [Journal-full-title] Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • [ISO-abbreviation] Ultrasound Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


3. Fèvre-Montange M, Champier J, Durand A, Wierinckx A, Honnorat J, Guyotat J, Jouvet A: Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol; 2009 Dec;35(6):1395-407
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Meningiomas, one of the largest subgroup of intracranial tumours are generally benign, but can progress to malignancy.
  • They are classified into the three World Health Organization grades: benign, atypical and anaplastic meningiomas.
  • Several genes have been suggested as prognostic factors, but molecular signatures have not permitted the classification of the tumours into the three grades.
  • Unsupervised hierarchical clustering classified the meningiomas into groups A, B and C, which corresponded to the three grades except for 3 benign meningiomas with higher proliferation indexes and/or recurrence, included in the atypical group.
  • Several genes involved in cell adhesion (CD44, LOX), cell division (CKS2, BIRC5 and UBE2C), cell differentiation (Notch1) or signal transduction (ARHGAP28) were upregulated, whereas tumour suppressor genes (LR1B, DRR1, PLZF, GPX3, SYNPO, TIMP3 and HOPS) and genes involved in cell adhesion (PROS1), proliferation (SERPINF1 and PDGFD) and differentiation (AOX1) were downregulated in groups B and C compared to group A.
  • In the benign tumours, we identified genes with signatures specific for fibroblastic meningiomas (FBLN1, Tenascin C and MMP2 encoding extracellular matrix proteins) and for meningothelial meningiomas (MLPH, DEFB1 and FAT3), suggesting different mechanisms involved in the tumorigenesis of these subtypes.
  • This microarray-based expression profiling study revealed candidate genes and pathways that may contribute to a better understanding of the recurrence of a benign meningioma.
  • Our results might make it possible to determine which benign meningiomas might recur despite complete resection, and will provide helpful information for neurosurgeons in the follow-up of the patients.
  • [MeSH-major] Gene Expression Profiling. Meningeal Neoplasms / genetics. Meningeal Neoplasms / pathology. Meningioma / genetics. Meningioma / pathology


Advertisement
4. Bassiony AA, Abdelrahman M, Abdelhady A, Assal MK: Resection arthrodesis for the management of aggressive giant cell tumor of the distal femur. Indian J Orthop; 2009 Jan;43(1):67-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resection arthrodesis for the management of aggressive giant cell tumor of the distal femur.
  • BACKGROUND: Giant cell tumors (GCTs) of bone are aggressive benign tumors.
  • Wide resection is reserved for a small subset of patients with biologically more aggressive, recurrent, and extensive tumors.
  • Wide resection and mobile joint reconstruction are preferable for treating tumors around the knee.
  • MATERIALS AND METHODS: Eight patients with mean age of 37.25 years (range 30-45 years) with Campanacci Grade III (Enneking stage III) giant cell tumors at the distal femur were treated with wide resection and arthrodesis using dual free fibular graft and locked intramedullary nail from January 2003 to January 2008.
  • The functional evaluation was done using the standard system of musculoskeletal tumor society with its modification developed by Enneking et al.
  • At final followup, all the patients were disease free.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Br. 1996 Mar;78(2):264-9 [8666639.001]
  • [Cites] Clin Orthop Relat Res. 1993 Jan;(286):241-6 [8425352.001]
  • [Cites] J Bone Joint Surg Am. 1998 May;80(5):636-47 [9611024.001]
  • [Cites] J Bone Joint Surg Am. 1999 Jun;81(6):811-20 [10391546.001]
  • [Cites] Arch Orthop Trauma Surg. 2000;120(3-4):215-8 [10738888.001]
  • [Cites] Clin Orthop Relat Res. 2001 Jul;(388):167-77 [11451116.001]
  • [Cites] J Bone Joint Surg Br. 2004 Jan;86(1):5-12 [14765857.001]
  • [Cites] Ann Acad Med Singapore. 2005 Apr;34(3):235-7 [15902343.001]
  • [Cites] J Surg Oncol. 2005 Oct 1;92(1):46-51 [16180228.001]
  • [Cites] Orthop Clin North Am. 2006 Jan;37(1):35-51 [16311110.001]
  • [Cites] Am J Clin Oncol. 2006 Feb;29(1):96-9 [16462511.001]
  • [Cites] J Bone Joint Surg Br. 2006 Dec;88(12):1642-6 [17159179.001]
  • [Cites] Indian J Orthop. 2007 Apr;41(2):124-8 [21139764.001]
  • [Cites] Indian J Orthop. 2007 Apr;41(2):129-33 [21139765.001]
  • [Cites] J Bone Joint Surg Am. 1990 Dec;72(10):1477-85 [2254355.001]
  • [Cites] J Bone Joint Surg Am. 1990 Apr;72(4):486-94 [2324134.001]
  • [Cites] J Orthop Res. 1989;7(4):463-7 [2738764.001]
  • [Cites] Clin Orthop Relat Res. 1987 Aug;(221):188-201 [3301143.001]
  • [Cites] Arch Orthop Trauma Surg. 1986;105(2):67-72 [3718192.001]
  • [Cites] J Bone Joint Surg Am. 1986 Sep;68(7):1073-9 [3745247.001]
  • [Cites] J Bone Joint Surg Am. 1987 Jan;69(1):106-14 [3805057.001]
  • [Cites] Cancer. 1970 May;25(5):1061-70 [4910256.001]
  • [Cites] J Bone Joint Surg Br. 1994 Mar;76(2):178-86 [8113272.001]
  • [Cites] J Bone Joint Surg Br. 1997 Jan;79(1):36-42 [9020442.001]
  • (PMID = 19753183.001).
  • [ISSN] 0019-5413
  • [Journal-full-title] Indian journal of orthopaedics
  • [ISO-abbreviation] Indian J Orthop
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2739496
  • [Keywords] NOTNLM ; Giant cell tumor / intra medullary nail / resection arthrodesis
  •  go-up   go-down


5. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH: The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol; 2007 Sep-Oct;8(5):390-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors.
  • OBJECTIVE: We wanted to evaluate the role of diffusion-weighted imaging (DWI) and the apparent diffusion coefficient (ADC) for detecting breast tumors, as compared with the T1- and T2-weighted images.
  • Sixty-five enhancing lesions were detected on the dynamic contrast-enhanced images and we used this as a reference image for detecting tumor.
  • Fifty-six breast lesions were detected on DWI and the histological diagnoses were as follows: 43 invasive ductal carcinomas, one mucinous carcinoma, one mixed infiltrative and mucinous carcinoma, seven ductal carcinomas in situ (DCIS), and four benign tumors.
  • We then compared the ADCs of the malignant and benign breast lesions to the ADCs of the normal fibroglandular tissue.
  • The mean ADCs of the invasive ductal carcinoma (0.89+/-0.18 x 10(-3)mm(2)/second) and DCIS (1.17+/-0.18 x 10(-3)mm(2)/ second) are significantly lower than those of the benign lesions (1.41+/-0.56 x 10(-3)mm(2)/second) and the normal fibroglandular tissue (1.51+/-0.29 x 10(-3)mm(2)/ second).
  • CONCLUSION: DWI has a high sensitivity for detecting breast tumors, and especially for detecting malignant breast tumors.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Breast Neoplasms / diagnosis. Carcinoma, Ductal, Breast / diagnosis. Carcinoma, Intraductal, Noninfiltrating / diagnosis. Diffusion Magnetic Resonance Imaging / methods

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Magn Reson Imaging. 2000 Dec;12(6):975-83 [11105039.001]
  • [Cites] J Comput Assist Tomogr. 2005 Sep-Oct;29(5):644-9 [16163035.001]
  • [Cites] Radiology. 2001 Jul;220(1):13-30 [11425968.001]
  • [Cites] AJR Am J Roentgenol. 2002 Jun;178(6):1403-9 [12034606.001]
  • [Cites] J Magn Reson Imaging. 2002 Jun;15(6):693-704 [12112520.001]
  • [Cites] J Magn Reson Imaging. 2002 Aug;16(2):172-8 [12203765.001]
  • [Cites] J Comput Assist Tomogr. 2002 Nov-Dec;26(6):1042-6 [12488758.001]
  • [Cites] Eur J Radiol. 2003 Mar;45(3):169-84 [12595101.001]
  • [Cites] Radiology. 2003 Oct;229(1):225-32 [14519877.001]
  • [Cites] J Magn Reson Imaging. 2004 Oct;20(4):654-61 [15390142.001]
  • [Cites] Stroke. 1997 Mar;28(3):481-2 [9056599.001]
  • [Cites] AJR Am J Roentgenol. 1998 Feb;170(2):397-402 [9456953.001]
  • [Cites] Radiology. 1998 Sep;208(3):605-9 [9722835.001]
  • [Cites] J Magn Reson Imaging. 1999 Jan;9(1):53-60 [10030650.001]
  • [Cites] AJR Am J Roentgenol. 1999 Aug;173(2):393-8 [10430143.001]
  • [Cites] JAMA. 2004 Dec 8;292(22):2735-42 [15585733.001]
  • [Cites] J Magn Reson Imaging. 2000 Dec;12(6):1014-9 [11105044.001]
  • (PMID = 17923781.001).
  • [ISSN] 1229-6929
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  • [Other-IDs] NLM/ PMC2626812
  •  go-up   go-down


6. Christacos NC, Quade BJ, Dal Cin P, Morton CC: Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer; 2006 Mar;45(3):304-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cytogenetic analysis of uterine leiomyomata (UL) shows that about 40% of these benign tumors have simple, clonal chromosomal rearrangements.
  • Several variants of benign uterine smooth-muscle tumors are defined by histologic phenotypes intermediate between typical UL and LMS, and currently, little is known about their cytogenetic and molecular genetic features.
  • Of eight UL for which the histologic diagnosis was known, four were diagnosed as cellular UL; one displayed both hypercellularity and nuclear atypia.
  • RNA from two UL with loss of 1p was profiled using Affymetrix GeneChips, and those profiles were compared to our previously reported smooth-muscle tumor expression profile.
  • The transcriptional profiles of tumors with 1p deletion were more similar to those of leiomyosarcoma than to profiles of myometrium and UL, as determined by hierarchical cluster analysis.
  • The similarity between the transcriptional profiles of LMS and UL with 1p-- suggests the possibility of a common pathogenetic mechanism.
  • [MeSH-major] Chromosome Aberrations. Chromosomes, Human, Pair 1 / genetics. Leiomyosarcoma / genetics. Myometrium / metabolism. Uterine Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16320247.001).
  • [ISSN] 1045-2257
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA78895; United States / NIGMS NIH HHS / GM / T32 GM0077
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


7. Lasota J, Wozniak A, Kopczynski J, Dansonka-Mieszkowska A, Wasag B, Mitsuhashi T, Sarlomo-Rikala M, Lee JR, Schneider-Stock R, Stachura J, Limon J, Miettinen M: Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases. Lab Invest; 2005 Feb;85(2):237-47
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
  • Mutational activation of KIT or PDGFRA is considered an early step in pathogenesis of gastrointestinal stromal tumors (GISTs); however, other nonrandom genetic changes have also been identified.
  • At least three common regions of deletions on chromosome 22q, which may harbor putative tumor suppressor genes, have been defined.
  • It has also been speculated that GI autonomous nerve tumors (GANTs), GISTs with ultrastructural features suggestive of autonomic nerve differentiation, are characterized by a specific deletion involving 22q13 cytogenetic region.
  • Four tumors were incidental minimal lesions <or=10 mm in diameter.
  • No NF2 mutations were identified in four analyzed tumors.
  • LOH on chromosome 22q was more frequent among intestinal than among gastric GISTs; however, there was no difference between LOH pattern seen in tumors defined by different histologic, ultrastructural (GANT) and molecular features (KIT and PDGFRA mutations).
  • Although minimal GISTs revealed LOH on chromosome 22q, there was a higher LOH frequency in malignant than in benign tumors.
  • An isolated LOH at D22S425 was equally found in both benign and malignant tumors.
  • These observations may suggest that LOHs on chromosome 22q in GISTs play a role in early stages of tumor formation as well as in late tumor progression.
  • [MeSH-major] Chromosomes, Human, Pair 22. Gastrointestinal Stromal Tumors / genetics. Loss of Heterozygosity

  • Genetic Alliance. consumer health - Chromosome 22q.
  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15580284.001).
  • [ISSN] 0023-6837
  • [Journal-full-title] Laboratory investigation; a journal of technical methods and pathology
  • [ISO-abbreviation] Lab. Invest.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Genetic Markers
  •  go-up   go-down


8. Schlemmer M: Desmoid tumors and deep fibromatoses. Hematol Oncol Clin North Am; 2005 Jun;19(3):565-71, vii-viii
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumors and deep fibromatoses.
  • Desmoid tumors (also called deep fibromatoses) are rare benign tumors associated with pregnancy and Gardner syndrome.
  • These tumors are characterized by bland-appearing fibroblasts, indistinct margins, and an ability to cause pathology by local invasion and recurrence.
  • This article highlights the biology and clinical features of desmoid tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15939197.001).
  • [ISSN] 0889-8588
  • [Journal-full-title] Hematology/oncology clinics of North America
  • [ISO-abbreviation] Hematol. Oncol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 44
  •  go-up   go-down


9. Garrido Abad P, Coloma del Peso A, Jiménez Gálvez M, Herranz Fernández LM, Arellano Gañán R, Reina Durán T: [Inflammatory myofibroblastic tumor. Case report]. Arch Esp Urol; 2008 Jan-Feb;61(1):62-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Inflammatory myofibroblastic tumor. Case report].
  • [Transliterated title] Tumor miofibroblástico inflamatorio vesical. Aportación de un nuevo caso.
  • OBJECTIVE: To report one case of myofibroblastic bladder tumor.
  • METHODS/RESULTS: We report the case of a 30-year-old woman with recurrent urinary tract infections and incidental finding of a bladder mass after abdominal ultrasound.
  • After TUR, inflammatory myofibroblastic tumor of the bladder was diagnosed.
  • CONCLUSION: Myofibroblastic tumor (also known as inflammatory pseudotumor or pseudosarcoma) is a benign tumor with mesenchymal origin.
  • It must not be misdiagnosed as a malignant neoplasm.
  • [MeSH-major] Leydig Cell Tumor / pathology. Urinary Bladder Neoplasms / pathology

  • Genetic Alliance. consumer health - Inflammatory myofibroblastic tumor.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18405029.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


10. Roh JL, Park CI: Function-preserving parotid surgery for benign tumors involving the deep parotid lobe. J Surg Oncol; 2008 Jul 1;98(1):42-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Function-preserving parotid surgery for benign tumors involving the deep parotid lobe.
  • BACKGROUND: Parotid deep lobe tumors have usually been removed by total parotidectomy, which has functional and aesthetic side effects.
  • METHODS: We evaluated functional outcomes in 19 patients undergoing limited partial parotidectomy for benign tumors, 11 with deep lobe tumors and 8 with tumors involving both superficial and deep lobes, who underwent partial parotidectomy with preservation of normal glandular parenchyma and limited dissection of the facial nerve.
  • No patient had tumor recurrence after a median follow-up of 40 months.
  • CONCLUSION: Limited resection of benign tumors involving the parotid deep lobe may result in improved functional outcomes, including preserved salivary flow and beneficial cosmetic aspects, without compromising local tumor control.
  • [MeSH-major] Minimally Invasive Surgical Procedures / methods. Parotid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18459159.001).
  • [ISSN] 1096-9098
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Ignee A, Piscaglia F, Ott M, Salvatore V, Dietrich CF: A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma. Scand J Gastroenterol; 2009;44(5):633-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma.
  • OBJECTIVE: To describe three patients with liver lesions mimicking malignant tumours diagnosed finally, using contrast-enhanced ultrasound, as cholangiocellular adenoma (bile duct adenoma).
  • In two patients, no primary liver tumour was found, and in the third patient, previously resected for breast cancer, a tissue specimen was considered useful for characterizing tumour receptors for more targeted chemotherapy, the lesion being assumed metastatic in nature.
  • CONCLUSION: Cholangiocellular adenoma is a rare entity and can be a reason for possible false malignant diagnosis using contrast-enhanced ultrasound.
  • [MeSH-major] Adenoma, Bile Duct / pathology. Bile Duct Neoplasms / pathology. Bile Ducts, Intrahepatic. Liver Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Image Enhancement / methods. Middle Aged. Phospholipids. Risk Assessment. Sampling Studies. Sulfur Hexafluoride. Ultrasonography, Doppler, Color

  • Genetic Alliance. consumer health - Liver Disease.
  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19396663.001).
  • [ISSN] 1502-7708
  • [Journal-full-title] Scandinavian journal of gastroenterology
  • [ISO-abbreviation] Scand. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Phospholipids; 0 / contrast agent BR1; WS7LR3I1D6 / Sulfur Hexafluoride
  •  go-up   go-down


12. Mahajan S, Srikant N, Boaz K, George T: Osteoblastoma of maxilla with cartilaginous matrix: review of literature and report of a case. Singapore Dent J; 2007 Dec;29(1):12-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteoblastoma of maxilla with cartilaginous matrix: review of literature and report of a case.
  • Osteoblastoma is a rare benign neoplasm of jaws.
  • We report a case of a recurrent osteoblastoma in the maxilla of a 34-year-old male who presented with aggressive clinical and histologic features: namely root resorption, tooth mobility, involvement of maxillary sinus, chondroid formation, host bone trapping, and lack of osteoblastic rimming.
  • [MeSH-major] Cartilage / pathology. Maxillary Neoplasms / pathology. Osteoblastoma / pathology
  • [MeSH-minor] Adult. Connective Tissue / pathology. Diagnosis, Differential. Humans. Male. Maxillary Sinus / pathology. Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology. Osteoblasts / pathology

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18472525.001).
  • [ISSN] 0377-5291
  • [Journal-full-title] Singapore dental journal
  • [ISO-abbreviation] Singapore Dent J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Singapore
  • [Number-of-references] 18
  •  go-up   go-down


13. Trovarelli S, Tallis V, Tripodi S, Miracco C, Ponchietti R: [Extratesticular intraescrotal neurofibroma: case report]. Arch Esp Urol; 2006 Nov;59(9):905-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Neurofibroma intraescrotal extratesticular: aportación de un caso.
  • METHODS: Clinical diagnosis of asymptomatic right scrotal lipoma and left symptomatic inguinal hernia carried the patient to the surgical treatment.
  • After the first surgical step of left hernia repair, we proceeded to the excision by an inguinoscrotal approach of a voluminous whitish neoplastic mass occupying the whole left scrotum and not involving homolateral testis.
  • RESULTS/CONCLUSIONS: The histopathologic diagnosis was of neurofibroma, a benign neoplasm of peripheral nerves which rarely occurs at genital level.
  • [MeSH-major] Genital Neoplasms, Male / pathology. Neurofibroma / pathology. Scrotum

  • Genetic Alliance. consumer health - Neurofibroma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17190215.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 9
  •  go-up   go-down


14. Abram S, Rosenblatt P, Holcomb S: Stereotactic radiation techniques in the treatment of acoustic schwannomas. 2007. Neurosurg Clin N Am; 2008 Apr;19(2):367-77, vii-viii
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The goals of the treatment of acoustic schwannomas are prohibiting tumor growth and alleviation of symptoms caused by damage to local structures.
  • These symptoms-tinnitus, ataxia, and hearing loss-secondary to eighth nerve dysfunction, as well as symptoms arising from damage to adjacent structures such as the facial nerve, trigeminal nerve, or pons, can be caused by tumor growth or treatment.
  • Determination of optimal therapy must also take into account an understanding of the natural history of the disease, because acoustic schwannomas are slow-growing benign tumors that when left untreated, usually enlarge over time and cause problems.

  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18534345.001).
  • [ISSN] 1558-1349
  • [Journal-full-title] Neurosurgery clinics of North America
  • [ISO-abbreviation] Neurosurg. Clin. N. Am.
  • [Language] eng
  • [Publication-type] Biography; Classical Article; Historical Article; Journal Article
  • [Publication-country] United States
  • [Personal-name-as-subject] Abram S; Rosenblatt P; Holcomb S
  •  go-up   go-down


15. Simon I, Rorive S, Kirkpatrick C, Roumeguere T, Nortier JL: Clear cell renal carcinoma presenting as a bleeding cyst in pregnancy: inaugural manifestation of a von Hippel-Lindau disease. Clin Nephrol; 2008 Mar;69(3):224-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell renal carcinoma presenting as a bleeding cyst in pregnancy: inaugural manifestation of a von Hippel-Lindau disease.
  • Von Hippel-Lindau (VHL) disease is a dominant autosomal disorder inducing the development of many tumors, such as hemangioblastomas in the central nervous system and retina, cysts or tumors (benign or malignant) in the kidneys and/or the pancreas.
  • We report the case of a pregnant woman who presented with a voluminous hemorrhagic cyst of the right kidney with an exophytic lesion detected in the lower median part of the cyst wall.
  • As an anamnestic inquiry resulted in a familial history of VHL disease, a screening imaging was performed and detected three medullary hemangioblastomas.
  • This case underlines the importance of screening procedures such as abdominal ultrasonography and medullary magnetic resonance imaging in all pregnant women with a familial history of VHL disease.
  • [MeSH-major] Carcinoma, Renal Cell / complications. Hematuria / etiology. Kidney Diseases, Cystic / diagnosis. Kidney Neoplasms / complications. Pregnancy Complications, Neoplastic. von Hippel-Lindau Disease / complications
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Nephrectomy / methods. Pregnancy


16. Huang CF, Chiou SY, Wu MF, Tu HT, Liu WS, Chuang JC: Apparent diffusion coefficients for evaluation of the response of brain tumors treated by Gamma Knife surgery. J Neurosurg; 2010 Dec;113 Suppl:97-104
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Apparent diffusion coefficients for evaluation of the response of brain tumors treated by Gamma Knife surgery.
  • The authors hypothesized that loss of tumor cells after Gamma Knife surgery (GKS) may alter the ADC value and used diffusion weighted MR imaging (DW imaging) to evaluate cellular changes in brain tumors to detect their treatment response and the efficacy of GKS.
  • Follow-up MR images and clinical outcomes were reviewed at 3-month intervals for metastatic lesions and at 6-month intervals for benign tumors.
  • Calcification (p = 0.006) and tumor recurrence (p = 0.025) significantly prevented a rise in the ADC level.The mean ADC value for all solid acoustic neuromas was 1.06 ± 0.17 × 10-3 mm2/sec before GKS.
  • At the last mean MR imaging follow-up there appeared to be tumor enlargement in 3 patients (12.5%); however, since the ADC values in these patients were significantly higher than the preradiosurgery values, the finding was considered to be a sign of radiation necrosis rather than tumor recurrence.
  • The mean ADC value of metastatic tumors was 1.05 ± 0.12 × 10-3 mm2/sec before GKS.
  • Magnetic resonance imaging showed that 89% of these tumors had been controlled by GKS.
  • In some patients in whom imaging findings are equivocal, ADC values may also be used to distinguish radiation-induced necrosis from tumor recurrence.(DOI: 10.3171/2010.7.GKS10864)
  • [MeSH-major] Brain Neoplasms / pathology. Brain Neoplasms / surgery. Diffusion Magnetic Resonance Imaging / methods. Image Processing, Computer-Assisted / methods. Radiosurgery / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Echo-Planar Imaging. Female. Humans. Male. Meningioma / pathology. Meningioma / surgery. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Neuroma, Acoustic / pathology. Neuroma, Acoustic / surgery. Tomography, X-Ray Computed. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21222290.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Bolca C, Saon C, Paleru C, Matache R, Codreşi M, Dănăilă O, Istrate A, Cadar G, Stoica R, Cordoş I: [Tracheal stenosis--diagnostic and therapeutic principles, results]. Pneumologia; 2010 Jul-Sep;59(3):132-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Stenozele traheale--principii de diagnostic şi tratament, rezultate.
  • Between November 2001-April 2010, 107 tracheal resections were performed in our department for different types of tracheal stenosis: iatrogenic or tumoral, benign or malignant.
  • We present the diagnosis and treatment principles that we used, along with our results.
  • We operated on 74 (69.15%) iatrogenic postintubation tracheal stenosis, 6 (5.6%) of them complicated with tracheo-esophageal fistula, 6 (5.6%) benign tumors, 11 (10.28%) primary malignant and 16 (14.97%) secondary malignant ones, with a 3.8% total mortality.
  • Interventional endoscopy is of a major importance in the assessment and treatment of tracheal stenosis.
  • [MeSH-major] Tracheal Stenosis / diagnosis. Tracheal Stenosis / surgery. Tracheoesophageal Fistula / diagnosis. Tracheoesophageal Fistula / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Anastomosis, Surgical / adverse effects. Child. Female. Humans. Intubation, Intratracheal / adverse effects. Male. Middle Aged. Neoplasms / complications. Neoplasms / surgery. Retrospective Studies. Risk Assessment. Risk Factors. Tracheostomy. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21058466.001).
  • [ISSN] 2067-2993
  • [Journal-full-title] Pneumologia (Bucharest, Romania)
  • [ISO-abbreviation] Pneumologia
  • [Language] rum
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


18. Shonaka T, Kurauchi N, Okawa Y, Misawa K, Sano H: [Case of solitary necrotic nodule of the liver difficult to distinguish from malignant hepatoma]. Nihon Shokakibyo Gakkai Zasshi; 2007 Jan;104(1):47-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In a 72 years old woman, abdominal computed tomography (CT) disclosed multicentric hypervascular tumor in S4 of the liver, and it was T1.T2 by the MRI, and a high signal was presented together.
  • Stenosis was shown by ERCP at the same site.
  • Later, a diagnosis of solitary necrotic nodule of the liver was established by pathological diagnosis.
  • Solitary necrotic nodule of the liver is a benign tumor.
  • [MeSH-major] Liver / pathology. Liver Diseases / diagnosis. Liver Neoplasms / diagnosis
  • [MeSH-minor] Aged. Carcinoma, Hepatocellular / diagnosis. Cholangiopancreatography, Endoscopic Retrograde. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Necrosis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17230006.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


19. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP: Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers; 2006 Apr-Jun;21(2):106-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human kallikrein 13 expression in salivary gland tumors.
  • The aim of this study was to determine whether hK13 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), in order to compare normal with tumor tissues.
  • The results of this study indicate that most salivary gland tumors show high levels of expression of hK13.
  • Ductal cells and cells lining duct-like structures showed a higher intensity of staining than non-ductal cells in most tumors.
  • Tumors which exhibited only non-ductal cells also exhibited cytoplasmic staining.
  • In conclusion, we demonstrate the high expression of hK13 in several common salivary gland tumors.
  • [MeSH-major] Biomarkers, Tumor. Carcinoma, Adenoid Cystic / metabolism. Gene Expression Regulation, Neoplastic. Kallikreins / biosynthesis. Mouth Mucosa / metabolism. Salivary Gland Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16847813.001).
  • [ISSN] 0393-6155
  • [Journal-full-title] The International journal of biological markers
  • [ISO-abbreviation] Int. J. Biol. Markers
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 3.4.21.- / KLK13 protein, human; EC 3.4.21.- / Kallikreins
  •  go-up   go-down


20. Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M, Lin Z: Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol; 2005 May;95(1-5):57-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Endometrial tissue from uterine disease-free women does not exhibit aromatase activity.
  • Aromatase mRNA levels and enzyme activity are also present in uterine leiomyomata that are estrogen-dependent benign tumors of the myometrium.
  • [MeSH-major] Aromatase / metabolism. Endometriosis / enzymology. Leiomyoma / enzymology. Uterine Neoplasms / enzymology

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16024248.001).
  • [ISSN] 0960-0760
  • [Journal-full-title] The Journal of steroid biochemistry and molecular biology
  • [ISO-abbreviation] J. Steroid Biochem. Mol. Biol.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD38691; United States / NICHD NIH HHS / HD / HD46260
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Aromatase Inhibitors; 0 / Estrogens; EC 1.14.14.1 / Aromatase
  • [Number-of-references] 32
  •  go-up   go-down


21. Hossain D, Meiers I, Qian J, MacLennan GT, Bostwick DG: Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases. Arch Pathol Lab Med; 2008 Nov;132(11):1729-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Prostatic stromal hyperplasia with atypia consists of 1 or more ill-defined, uncircumscribed, hyperplastic stromal nodules, with variable numbers of atypical, bizarre giant cells, with vacuolated nuclei, smudged chromatin, and frequent multinucleation infiltrating around benign acini.
  • CONCLUSIONS: Prostatic stromal hyperplasia with atypia is a rare, benign lesion, composed of degenerative myocytes with atypia that is histologically and clinically reminiscent of benign counterparts in the myometrium, breast, vulva, vagina, and elsewhere.
  • Recognition of this distinctive entity should allow separation from phyllodes tumor and sarcoma of the prostate.
  • The phrase stromal tumor of uncertain malignant potential is inappropriate for this benign tumor, and its use is discouraged.
  • [MeSH-major] Prostatic Hyperplasia / diagnosis. Prostatic Hyperplasia / pathology. Stromal Cells / pathology
  • [MeSH-minor] Aged. Aged, 80 and over. Cell Nucleus / pathology. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Middle Aged. Muscle Cells / metabolism. Muscle Cells / pathology. Receptors, Androgen / metabolism. Retrospective Studies. Vimentin / metabolism

  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18976007.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Androgen; 0 / Vimentin
  •  go-up   go-down


22. Passman C, Urban D, Klemm K, Lockhart M, Kenney P, Kolettis P: Testicular lesions other than germ cell tumours: feasibility of testis-sparing surgery. BJU Int; 2009 Feb;103(4):488-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Testicular lesions other than germ cell tumours: feasibility of testis-sparing surgery.
  • OBJECTIVE: To review all non-germ-cell testicular lesions presenting at our institution and to determine the feasibility of testis-sparing surgery for these patients.
  • Patients with atrophy, germ cell tumours, infection or torsion were excluded.
  • The study comprised men who had radical orchidectomy for suspected germ-cell tumour but had other final pathology, and those where testis-sparing surgery was attempted for a presumed benign lesion.
  • The lesions could be categorized as inflammatory (three hyalinized fibrosis, two sarcoidosis, one chronic inflammation), cystic (one epidermoid cyst, one unilocular cyst), benign neoplasms (two adenomatoid tumours, one Leydig cell tumour, one capillary haemangioma) or malignant neoplasms (one lymphoma).
  • In the other five, testis-sparing surgery was not attempted because the preoperative impression was that of a germ cell tumour.
  • CONCLUSION: Testis-sparing surgery might be possible if there is significant suspicion of a benign lesion.
  • [MeSH-minor] Adolescent. Adult. Aged. Feasibility Studies. Humans. Leydig Cell Tumor / pathology. Leydig Cell Tumor / surgery. Leydig Cell Tumor / ultrasonography. Male. Middle Aged. Neoplasms, Germ Cell and Embryonal / pathology. Neoplasms, Germ Cell and Embryonal / surgery. Retrospective Studies. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Testicular Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18793303.001).
  • [ISSN] 1464-410X
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


23. Rotman S, Déruaz C, Venetz JP, Chaubert P, Benhattar J, Meuwly JY, Jichlinski P, Guillou L, Moll S, Pascual M, Lemoine R: De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin. Hum Pathol; 2006 Apr;37(4):481-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin.
  • In the general population, renal cell carcinoma (RCC) is a relatively common neoplasm; however, the papillary RCC subtype is infrequent and represents only 10 to 15% of all RCC.
  • Angiomyolipoma is a well-known common benign tumor.
  • In transplant recipients, RCC can develop in native kidneys, but its occurrence "de novo" in the renal allograft is very rare with an estimated incidence of less than 0.5%.
  • We report here the case of a 39-year-old woman who underwent cadaveric renal transplantation in 1990.
  • She underwent allograft nephrectomy and the histologic findings revealed that one of the tumors was a chromophilic (type 1) papillary RCC (2.5 cm in diameter) and the other, an angiomyolipoma (1.5 cm).
  • Microsatellite analysis of the allograft, as compared with the recipient peripheral blood leukocytes, demonstrated that the 2 tumors (1 malignant and 1 benign) were of donor origin.
  • To our knowledge, this is the first report of de novo concurrent papillary RCC and angiomyolipoma in a renal allograft.
  • [MeSH-major] Angiomyolipoma / etiology. Carcinoma, Renal Cell / etiology. Kidney Neoplasms / etiology. Kidney Transplantation / adverse effects. Tissue Donors
  • [MeSH-minor] Adult. Cadaver. Female. Humans. Male. Microsatellite Repeats. Neoplasms, Multiple Primary. Nephrectomy. Postoperative Complications. Reoperation


24. Ogbole G, Kazaure I, Anas I: Quadrigeminal plate cistern lipoma. BMJ Case Rep; 2009;2009
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intracranial lipomas are rare benign neoplasms accounting for <0.1% of all primary brain tumours.
  • Most lipomas were incidentally detected by autopsy or computed tomography (CT).These slow growing benign lesions are usually asymptomatic and rarely require surgery.
  • We report the case of a 70-year-old Nigerian woman who presented with persistent headaches following involvement in a road traffic accident 20 days previously.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22190982.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3027879
  •  go-up   go-down


25. Hedayati P, VanSonnenberg E, Shamos R, Gillespie T, McMullen W: Treatment of symptomatic focal nodular hyperplasia with percutaneous radiofrequency ablation. J Vasc Interv Radiol; 2010 Apr;21(4):582-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The authors report a case of a 21-year-old woman taking oral contraceptives for severe dysmenorrhea who presented with a hepatic mass and worsening right upper quadrant pain.
  • The ablation proved to be a safe and effective alternative to surgery to treat the benign tumor, and permitted more aggressive therapy of the dysmenorrhea.
  • [MeSH-major] Catheter Ablation / methods. Liver Neoplasms / radiography. Liver Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 SIR. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20138547.001).
  • [ISSN] 1535-7732
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Moaath A, Raed E, Mohammad R, Mohammad S: Lipoblastoma: a rare mediastinal tumor. Ann Thorac Surg; 2009 Nov;88(5):1695-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lipoblastoma: a rare mediastinal tumor.
  • Lipoblastoma is a rare benign mesenchymal tumor of embryonal fat that occurs almost exclusively in infants and children less than age 3.
  • It is a benign tumor with a high recurrence rate.
  • We emphasize that this rare mediastinal tumor should be included in the differential diagnosis of infants having a mediastinal mass.
  • [MeSH-major] Mediastinal Neoplasms / diagnosis. Neoplasms, Adipose Tissue / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19853146.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


27. Grosheva M, Gerharz M, Bovenschulte H, Beutner D: [Adult multilocular rhabdomyoma as a rare cause of dysphagia]. Laryngorhinootologie; 2008 Sep;87(9):651-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Multilokuläre adulte Rhabdomyome als seltene Ursache einer Dysphagie.
  • BACKGROUND: Adult rhabdomyoma is a benign tumor of the cardial und skeletal muscle system.
  • After complete surgical resection, histological investigation confirmed the diagnosis of a multilocular adult rhabdomyoma.
  • CONCLUSION: Rhabdomyoma as a benign lesion could occur multilocular and simulate metastasis of a malign formation.
  • [MeSH-major] Deglutition Disorders / etiology. Head and Neck Neoplasms. Rhabdomyoma

  • Genetic Alliance. consumer health - Dysphagia.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Swallowing Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18833645.001).
  • [ISSN] 0935-8943
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


28. Daponte A, Kostopoulou E, Kollia P, Papamichali R, Vanakara P, Hadjichristodoulou C, Nakou M, Samara S, Koukoulis G, Messinis IE: L1 (CAM) (CD171) in ovarian serous neoplasms. Eur J Gynaecol Oncol; 2008;29(1):26-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] L1 (CAM) (CD171) in ovarian serous neoplasms.
  • PURPOSE OF THE INVESTIGATION: The evaluation of L1 (CAM) as a tumor progression marker and as a prognostic factor in serous ovarian tumors.
  • METHODS: L1 (CAM) protein expression was assessed by immunohistochemistry and Western blot in serous ovarian tumors [cystadenomas (n = 20), borderline tumors (n = 14) and carcinomas (n = 47)], and was correlated with stage,grade, progression-free survival time (PFS) and overall survival.
  • It increased from benign tumors to early carcinomas and to advanced stage carcinomas progressively and significantly.
  • In Stage III G3 carcinoma patients, low L1 (CAM) expressing tumors exhibited better response to chemotherapy and were associated with statistically significantly longer PFS (p = 0.002).
  • CONCLUSION: L1 (CAM) expression represents a novel diagnostic marker in serous ovarian neoplasms that shows characteristics of tumor progression.
  • [MeSH-major] Biomarkers, Tumor. Disease-Free Survival. Neoplasms, Cystic, Mucinous, and Serous / metabolism. Neural Cell Adhesion Molecule L1 / metabolism. Ovarian Neoplasms / metabolism
  • [MeSH-minor] Female. Follow-Up Studies. Humans. Immunohistochemistry. Kaplan-Meier Estimate. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18386459.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neural Cell Adhesion Molecule L1
  •  go-up   go-down


29. Damadoglu E, Salturk C, Takir HB, Ertugrul M, Yilmaz A, Atasalihi A, Yilmaz A: Mediastinal thymolipoma: an analysis of 10 cases. Respirology; 2007 Nov;12(6):924-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thymolipoma is a benign tumour composed of thymic elements and adipose tissue.
  • Thymolipomas are unusual tumours and may be associated with myasthenia gravis.
  • [MeSH-major] Mediastinal Neoplasms / diagnosis. Thymoma / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17986126.001).
  • [ISSN] 1323-7799
  • [Journal-full-title] Respirology (Carlton, Vic.)
  • [ISO-abbreviation] Respirology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


30. Hong TH, Lee SK, You YK, Kim JG: Single-port laparoscopic partial splenectomy: a case report. Surg Laparosc Endosc Percutan Tech; 2010 Oct;20(5):e164-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With the better understanding of the importance of the spleen as a primary organ of the human immune system, there has been an increased interest in performing the partial splenectomy for a number of indications such as nonparasitic cysts, benign tumors, staging of lymphomas, etc.
  • Moreover, laparoscopic partial splenectomy has been gaining more interest as the recommended approach for benign splenic disorders to preserve the splenic function with very low recurrence rates.
  • Here, we describe a feasible method of single-port laparoscopic partial splenectomy for treating a benign splenic cyst that was located in the upper medial aspect of the spleen.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20975492.001).
  • [ISSN] 1534-4908
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Gorgun M, Sezer TO, Kirdok O: Laparoscopic resection of retroperitoneal schwannoma near the inferior vena. Ann Vasc Surg; 2010 May;24(4):551.e1-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Schwannomas are usually benign tumors that arise from the schwann cells in the neural sheaths of peripheral nerves.
  • We report a successfully resected retroperitoneal benign schwannoma near the inferior vena cava (IVC) using laparoscopic surgery.
  • Magnetic resonance imaging confirmed the existence of a round, sharply demarcated retroperitoneal solid tumor, 42 x 52 mm in size, located between the anterior of the right kidney and the IVC, which was compressed but still patent.
  • CONCLUSION: Laparoscopic surgery is very useful and feasible in the diagnosis and treatment of retroperitoneal schwannoma, with minimal invasiveness and early postoperative recovery.
  • [MeSH-major] Laparoscopy. Neurilemmoma / surgery. Retroperitoneal Neoplasms / surgery

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20144535.001).
  • [ISSN] 1615-5947
  • [Journal-full-title] Annals of vascular surgery
  • [ISO-abbreviation] Ann Vasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Ishoo E: Intramuscular myxoma presenting as a rare posterior neck mass in a young child: case report and literature review. Arch Otolaryngol Head Neck Surg; 2007 Apr;133(4):398-401
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intramuscular myxoma (IMM) is an uncommon benign tumor that presents as a slow-growing, deep-seated mass confined to the skeletal muscle.
  • These tumors most often present as painless, deep-seated intramuscular masses that may exhibit symptoms of compression of surrounding structures.(1) I report a case of a 22-month-old girl with an IMM in the posterior cervical triangle.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Muscle Neoplasms / diagnosis. Myxoma / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Infant. Magnetic Resonance Imaging. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17438256.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  •  go-up   go-down


33. Chien AL, Song DH, Stein SL: Two young girls with lipoblastoma and a review of the literature. Pediatr Dermatol; 2006 Mar-Apr;23(2):152-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lipoblastoma is an uncommon, benign tumor of embryonic adipose tissue that occurs predominantly in the pediatric population.
  • Biopsy of the lesion is standard for diagnosis, as clinical and radiologic diagnoses can be misleading.
  • Both tumors were excised and subsequent gross and histopathologic examination demonstrated features of lipoblastoma.
  • [MeSH-major] Lipoma / diagnosis
  • [MeSH-minor] Child, Preschool. Diagnosis, Differential. Female. Groin. Heel. Humans. Infant

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16650226.001).
  • [ISSN] 0736-8046
  • [Journal-full-title] Pediatric dermatology
  • [ISO-abbreviation] Pediatr Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 24
  •  go-up   go-down


34. Lai TK, Chung CH, Chin AC, Szeto PS, Wong WC, Chan RY, Huang HY, Ng WF: Magnetic resonance imaging for ureteral fibroepithelial polyp. Hong Kong Med J; 2008 Oct;14(5):408-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ureteric tumours are rare and most of them are malignant.
  • Of benign tumours, ureteral fibroepithelial polyps are the most common but are still considered clinical rarities.
  • In the past, most benign ureteric tumours were only diagnosed after surgical removal.
  • Non-contrast enhanced magnetic resonance urography can produce an image comparable to an intravenous urogram without use of intravenous water-soluble contrast.
  • Nevertheless, a definitive diagnosis relies on ureteroscopic examination with biopsy.
  • When a non-obstructive polyp is being managed conservatively, imaging is helpful for monitoring.

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18840916.001).
  • [ISSN] 1024-2708
  • [Journal-full-title] Hong Kong medical journal = Xianggang yi xue za zhi
  • [ISO-abbreviation] Hong Kong Med J
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


35. Wang X, Pogue BW, Jiang S, Dehghani H, Song X, Srinivasan S, Brooksby BA, Paulsen KD, Kogel C, Poplack SP, Wells WA: Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography. J Biomed Opt; 2006 Jul-Aug;11(4):041106
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Then the method was used in NIR patient images, and it indicates that for a cancer tumor, the effective scatterer size is smaller than the background breast values and the effective number density is higher.
  • In contrast, for benign tumor patients, there is not a significant difference in effective scatterer size or number density between tumor and normal tissues.
  • [MeSH-major] Breast / pathology. Breast Neoplasms / diagnosis. Image Enhancement / methods. Image Interpretation, Computer-Assisted / methods. Infrared Rays. Refractometry / methods. Tomography, Optical / methods

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16965134.001).
  • [ISSN] 1083-3668
  • [Journal-full-title] Journal of biomedical optics
  • [ISO-abbreviation] J Biomed Opt
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01CA80139; United States / NCI NIH HHS / CA / U54CA105480
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


36. Chen Y, Tian K, Geng N, Yang MZ, Zhang WP: [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan;40(1):58-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To examine the expression of MMPs and TIMPs in pleomorphic adenoma of salivary gland and to investigate the relationship between the expression and the biological behaviour of the tumor.
  • Immunohistochemistry for MMP-2, MMP-9, TIMP-1, TIMP-2 and gelatin zymography analysis were performed in these 23 cases and in 6 malignant and 6 benign salivary gland tumors.
  • There was no significant difference in expression of MMP-2, MMP-9, TIMP-1 and TIMP-2 between the salivary malignant tumor and active pleomorphic adenoma, also between the salivary benign tumor and common pleomorphic adenoma.
  • [MeSH-major] Adenoma, Pleomorphic / metabolism. Matrix Metalloproteinase 2 / metabolism. Matrix Metalloproteinase 9 / metabolism. Salivary Gland Neoplasms / metabolism. Tissue Inhibitor of Metalloproteinase-1 / metabolism. Tissue Inhibitor of Metalloproteinase-2 / metabolism

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15774155.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Tissue Inhibitor of Metalloproteinase-1; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24 / MMP2 protein, human; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


37. Colović N, Colović R, Grubor N, Micev M, Radak V, Stojković M: [Inflammatory pseudotumor of the spleen]. Vojnosanit Pregl; 2006 Aug;63(8):757-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Inflammatory pseudotumors are benign tumor lesions of an unknown etiology that can appear almost at any organ, sometimes along with infectious agens, like Epstein-Barr virus.
  • Symptoms are either absent or uncharacteristic, so that the tumors are discovered by chance or during investigations of other diseases.
  • Splenectomy was performed due to a suspected lymphoproliferative disorder.
  • The exact diagnosis can be established only by histology and/or immunohistochemistry of the spleen removed for a suspected lymphoproliferative disorder, most frequently lymphoma.
  • [MeSH-major] Granuloma, Plasma Cell / diagnosis. Splenic Diseases / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Spleen Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16918163.001).
  • [ISSN] 0042-8450
  • [Journal-full-title] Vojnosanitetski pregled
  • [ISO-abbreviation] Vojnosanit Pregl
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia and Montenegro
  •  go-up   go-down


38. El Kohen A, Lahlou M, Rabeh G, Benjelloun A, Lazrak A, Jazouli N, Kzadri M: [Orbital osteoma: clinical evaluation of nine cases]. Rev Stomatol Chir Maxillofac; 2005 Feb;106(1):7-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Les ostéomes orbitaires: évaluation clinique de neuf cas.
  • RESULTS: Clinical signs were dominated by ophthalmological disorders, basically non-reducible exophthalmia (n = 8).
  • En bloc resection (n = 4) or fragmentation (n = 4) was performed.
  • DISCUSSION: Frontoethmoidal osteoma is a relatively rare benign tumor.
  • Imaging provides the positive diagnosis and guides the surgical approach.
  • Therapeutic indications depend on the tumor size, its course, and the development of complications.
  • [MeSH-major] Orbital Neoplasms / surgery. Osteoma / surgery
  • [MeSH-minor] Adolescent. Adult. Diplopia / etiology. Ethmoid Sinus / surgery. Exophthalmos / etiology. Female. Follow-Up Studies. Frontal Sinus / surgery. Humans. Male. Maxillary Sinus / surgery. Nasal Obstruction / etiology. Paranasal Sinus Neoplasms / diagnosis. Paranasal Sinus Neoplasms / surgery. Postoperative Complications. Sinusitis / etiology. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15798645.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


39. Singh R, Jain M, Siwach R, Rohilla RK, Kaur K: Unusual presentation of bizarre parosteal osteochondromatous lesion of the second toe (Nora's lesion). Foot Ankle Spec; 2010 Dec;3(6):347-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bizarre parosteal osteochondromatous proliferation (BPOP) of bone is a rare benign neoplasm.
  • Although local excision of the tumor is the treatment of choice, the authors resorted to ray excision, as gangrenous changes and ulceration were present and there was the possibility of malignant change.
  • [MeSH-major] Bone Neoplasms / pathology. Foot Ulcer / pathology. Osteochondroma / pathology. Periosteum / pathology. Toes / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20624925.001).
  • [ISSN] 1938-7636
  • [Journal-full-title] Foot & ankle specialist
  • [ISO-abbreviation] Foot Ankle Spec
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


40. de Koning HD, Bovenschen HJ: Two adjacent nodules on the leg. Dermatol Online J; 2010;16(6):13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Poroma is a rare benign neoplasm (derived from the intraepidermal part of the eccrine or apocrine duct), which may clinically mimic malignant tumors such as (amelanotic) malignant melanoma and porocarcinoma.
  • Histopathological examination is the key to the correct diagnosis, which is illustrated in the present case, in which a pigmented basal cell carcinoma and a poroma are in close proximity to each other.
  • Despite a clinical differential diagnosis of melanoma, histopathology showed the typical characteristics of a poroma, a rare but much more favorable tumor.
  • [MeSH-major] Carcinoma, Basal Cell / diagnosis. Leg. Poroma / diagnosis. Sweat Gland Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20579468.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Han B, Jiang G, Wang H, He W, Liu M, Song N: Benign clear cell tumor of the lung. Ann Thorac Surg; 2010 Jun;89(6):2012-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign clear cell tumor of the lung.
  • Clear cell tumor of the lung is a rare benign tumor.
  • Herein, we present a case of a 51-year-old man who had an abnormal pulmonary nodule occasionally found on chest roentgenogram.
  • The patient underwent a lobectomy for the tumor.
  • The pathologic report supported the diagnosis of clear cell tumor of the lung.
  • [MeSH-major] Lung Neoplasms

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20494071.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


42. Uysal A, Sungur N, Koçer U, Cöloğlu H, Oruç M, Yalta T: Neuromuscular hamartoma of the occipital nerve: clinical report. J Craniofac Surg; 2005 Jul;16(4):740-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neuromuscular hamartoma is a rare benign tumor consisted of well-differentiated striated muscle fibers within mature neural elements.
  • Though most cases are composed of solitary masses associated with major peripheral nerves, multiple tumors or subcutaneous tumors without any association with peripheral nerves have also been reported.
  • There have been no reports of this tumor in association with the occipital nerve.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16077331.001).
  • [ISSN] 1049-2275
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Suzuki M, Sakurai H, Seno S, Hoshi J, Ogawa T, Arikata M, Tojima I, Kitanishi T, Tanaka H, Shimizu T: [Endoscopic resection of benign and malignant tumors in the nasal cavity and paranasal sinus]. Nihon Jibiinkoka Gakkai Kaiho; 2005 Jul;108(7):724-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Endoscopic resection of benign and malignant tumors in the nasal cavity and paranasal sinus].
  • Endoscopic resection of nasal and paranasal sinus tumors is more aesthetic and less invasive than conventional resection, such as Luc's operation and lateral rhinotomy.
  • We clarified the effect of radical endoscopic tumor excision and the control of local bleeding hazardous in endoscopic surgery.
  • Subjects were patients with benign lesions in the nasal cavity, medial wall of the maxillary sinus, ethmoid sinus, and/or sphenoid sinus without concurrent malignant lesions.
  • Although patients selection for malignant tumor excision was based on (1) possible en bloc resection, (2) low-grade malignant tumors, and (3) tumors in the nasal cavity and adjoining paranasal sinus, the final decision was made individual.
  • Subjects were 23 patients with benign tumor (10 inverted papilloma, 9 hemangioma, 2 juvenile angiofibroma, and 2 other tumors) and 4 with malignant tumor (olfactory neuroblastoma, acinic cell carcinoma, squamous cell carcinoma, and chondroid chordoma) in the nasal and paranasal sinus.
  • The tumor was resected en bloc except for patients with inverted papilloma (2 cases) and chondroid chordoma.
  • Recurrence in benign tumors was zero during a mean observation of 21 months.
  • The endoscopic excision of benign lesions in the nasal and paranasal sinus is thus as effective as conventional radical surgery.
  • [MeSH-major] Endoscopy. Nasal Cavity. Nose Neoplasms / surgery. Paranasal Sinus Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16107047.001).
  • [ISSN] 0030-6622
  • [Journal-full-title] Nihon Jibiinkoka Gakkai kaiho
  • [ISO-abbreviation] Nippon Jibiinkoka Gakkai Kaiho
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


44. Liu J, Zheng S, Yu JK, Zhang JM, Chen Z: Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor. J Zhejiang Univ Sci B; 2005 Jan;6(1):4-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
  • To screen and evaluate protein biomarkers for the detection of gliomas (Astrocytoma grade I-IV) from healthy individuals and gliomas from brain benign tumors by using surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) coupled with an artificial neural network (ANN) algorithm.
  • SELDI-TOF-MS protein fingerprinting of serum from 105 brain tumor patients and healthy individuals, included 28 patients with glioma (Astrocytoma I-IV), 37 patients with brain benign tumor, and 40 age-matched healthy individuals.
  • An accuracy of 95.7%, sensitivity of 88.9%, specificity of 100%, positive predictive value of 90% and negative predictive value of 100% were obtained in a blinded test set comparing gliomas patients with healthy individuals; an accuracy of 86.4%, sensitivity of 88.9%, specificity of 84.6%, positive predictive value of 90% and negative predictive value of 85.7% were obtained when patient's gliomas was compared with benign brain tumor.
  • The high sensitivity and specificity achieved by the use of selected biomarkers showed great potential application for the discrimination of gliomas patients from healthy individuals and gliomas from brain benign tumors.
  • [MeSH-major] Astrocytoma / blood. Astrocytoma / diagnosis. Biomarkers, Tumor / blood. Brain Neoplasms / blood. Brain Neoplasms / diagnosis. Diagnosis, Computer-Assisted / methods. Neoplasm Proteins / blood. Peptide Mapping / methods

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26 [12568441.001]
  • [Cites] Pain. 2003 Apr;102(3):251-6 [12670666.001]
  • [Cites] Curr Med Chem. 2003 May;10(10):831-43 [12678686.001]
  • [Cites] J Clin Oncol. 2003 May 15;21(10 Suppl):200s-205s [12743135.001]
  • [Cites] Lung Cancer. 2003 Jun;40(3):267-79 [12781425.001]
  • [Cites] Curr Pharm Biotechnol. 2004 Feb;5(1):45-67 [14965209.001]
  • [Cites] Curr Opin Biotechnol. 2004 Feb;15(1):24-30 [15102462.001]
  • [Cites] Electrophoresis. 2000 Apr;21(6):1164-77 [10786889.001]
  • [Cites] N Engl J Med. 2001 Jan 11;344(2):114-23 [11150363.001]
  • [Cites] Bioinformatics. 2002 Mar;18(3):395-404 [11934738.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1160-9 [12142368.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1296-304 [12142387.001]
  • [Cites] Clin Cancer Res. 2002 Aug;8(8):2541-52 [12171882.001]
  • (PMID = 15593384.001).
  • [ISSN] 1673-1581
  • [Journal-full-title] Journal of Zhejiang University. Science. B
  • [ISO-abbreviation] J Zhejiang Univ Sci B
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Controlled Clinical Trial; Letter; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  • [Other-IDs] NLM/ PMC1390751
  •  go-up   go-down


45. Rosato L, Mondini G, Serbelloni M, Bertone P, Orlassino R, Cossavella D: [Intra-abdominal desmoid tumors: rare but important disease]. G Chir; 2007 Jan-Feb;28(1-2):20-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intra-abdominal desmoid tumors: rare but important disease].
  • [Transliterated title] I tumori desmoidi intra-addominali: una patologia rara, mai importante.
  • Desmoid tumors are rare benign neoplasms with high tendency to local recurrence, and they can be divided into extra- and intra-abdominal types (mesenteric fibromatosis).
  • Six patients (3 men and 3 women) affected by extra-abdominal desmoid tumors have been treated with radical excision.
  • 1) a 55 years old man admitted for acute abdomen and submitted, in emergency, to a laparotomy with excision of a mesenteric abscess including a jejunal loop at about one meter from Treitz;.
  • 2) 52 years old man, submitted to an elective excision of a capsulated neoplasm of the little omentum, which had caused an oppressive abdominal pain.
  • In both cases the hystological diagnosis has been desmoid tumor.
  • Surgical treatment of desmoid tumors must aim at radical excision to avoid frequent recurrences (25-65%); these have stimulated the research of other kinds of treatments, since a new surgical operation itself can lead to a further recurrence.
  • Radiotherapy has been investigated with results in 79-96% of cases, antiestrogenic therapy has been used with success in 51% of patients, and high dose tamoxifen seemed to obtain a stable disease in non operable cases.
  • Non steroidal anti-inflammatory drugs have been experimented in association with tamoxifen and chemotherapy.
  • Conclusive results on the efficacy of these treatments have not been obtained yet, because of the rarity of the desmoid tumors even in greater Centres.
  • [MeSH-major] Fibromatosis, Abdominal / surgery. Mesentery. Peritoneal Neoplasms / surgery
  • [MeSH-minor] Abdominal Neoplasms / pathology. Abdominal Neoplasms / surgery. Aged. Female. Fibromatosis, Aggressive / surgery. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17313728.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


46. Shcherbakov PL, Bystrovskaia EV, Dolgasheva GM, Orlova IuN: [Endosonography in the diagnostics of non-epithelial tumors of the esophagus, stomach and duodenum]. Eksp Klin Gastroenterol; 2010;(10):29-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Endosonography in the diagnostics of non-epithelial tumors of the esophagus, stomach and duodenum].
  • Non-epithelial tumors account for 5% of all neoplasms of the gastrointestinal (GI) tract, most often have no clinical manifestations and they are finding during the endoscopy.
  • Endoscopic ultrasonography (EUS) significantly expands the possible differential diagnosis of submucosal formations on the basis of their ultrasound characteristics.
  • The article presents the literature and personal experience of differential diagnosis of non-epithelial tumors, and benign formations of the esophagus, stomach and duodenum wall.
  • [MeSH-major] Duodenal Neoplasms / ultrasonography. Endosonography / methods. Esophageal Neoplasms / ultrasonography. Stomach Neoplasms / ultrasonography
  • [MeSH-minor] Biopsy, Fine-Needle. Diagnosis, Differential. Humans. Mucous Membrane / pathology. Mucous Membrane / ultrasonography

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21434368.001).
  • [ISSN] 1682-8658
  • [Journal-full-title] Ėksperimental'nai︠a︡ i klinicheskai︠a︡ gastroėnterologii︠a︡ = Experimental & clinical gastroenterology
  • [ISO-abbreviation] Eksp Klin Gastroenterol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


47. Sherrod QJ, Chiu MW, Gutierrez M: Multiple pilomatricomas: cutaneous marker for myotonic dystrophy. Dermatol Online J; 2008;14(7):22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pilomatricoma (calcifying epithelioma of Malherbe) is a benign tumor of hair matrix derivation.
  • Since the onset of MPs may precede the signs of myotonic dystrophy, they can serve as potential early cutaneous markers for this systemic disease.
  • [MeSH-major] Biomarkers, Tumor / analysis. Hair Diseases / pathology. Myotonic Dystrophy / pathology. Pilomatrixoma / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Myotonic dystrophy.
  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18718206.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


48. Boo YJ, Kim J, Kim JH, Kim CS, Suh SO: Inflammatory myofibroblastic tumor of the kidney in a child: report of a case. Surg Today; 2006;36(8):710-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory myofibroblastic tumor of the kidney in a child: report of a case.
  • Inflammatory myofibroblastic tumor (IMT), also known as inflammatory pseudotumor, is an uncommon benign tumor that has been reported in various locations throughout the body, but rarely in the kidney.
  • Renal IMT in children is difficult to differentiate from a malignancy such as Wilms' tumor.
  • We report a case of a 9-year old girl with a left renal mass mimicking malignancy on preoperative diagnostic images, which was pathologically revealed to be an IMT.
  • We review the literature and discuss the pathophysiology and clinical features of this unusual tumor.
  • [MeSH-major] Granuloma, Plasma Cell / diagnosis. Kidney Diseases / diagnosis
  • [MeSH-minor] Child. Diagnosis, Differential. Female. Humans. Kidney Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Inflammatory myofibroblastic tumor.
  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Esp Urol. 2002 Jan-Feb;55(1):85-7 [11957761.001]
  • [Cites] Acta Cytol. 2000 May-Jun;44(3):478-80 [10834015.001]
  • [Cites] Int J Urol. 2004 May;11(5):337-9 [15147553.001]
  • [Cites] Actas Urol Esp. 2003 Oct;27(9):739-41 [14626687.001]
  • [Cites] Yonsei Med J. 2000 Jun;41(3):401-3 [10957897.001]
  • [Cites] Int Urol Nephrol. 2004;36(2):141-3 [15368680.001]
  • [Cites] J Pediatr Surg. 2005 Mar;40(3):597-9 [15793747.001]
  • [Cites] Am J Nephrol. 2000 May-Jun;20(3):217-21 [10878405.001]
  • [Cites] J Clin Pathol. 2003 Nov;56(11):868-70 [14600136.001]
  • [Cites] Am J Surg Pathol. 2003 May;27(5):658-66 [12717250.001]
  • [Cites] Am J Surg Pathol. 1992 Dec;16(12):1233-8 [1463096.001]
  • [Cites] J Pediatr Surg. 1988 Aug;23(8):755-8 [3171847.001]
  • [Cites] Int J Urol. 1999 Feb;6(2):107-10 [10226817.001]
  • [Cites] Semin Diagn Pathol. 1998 May;15(2):85-101 [9606801.001]
  • [Cites] Am J Kidney Dis. 1998 Jun;31(6):E5 [10074585.001]
  • [Cites] Arch Surg. 1991 May;126(5):653-5 [1826994.001]
  • [Cites] J Urol. 1972 Jun;107(6):938-9 [5033977.001]
  • [Cites] Am J Pathol. 2000 Aug;157(2):377-84 [10934142.001]
  • [Cites] South Med J. 1998 Nov;91(11):1050-3 [9824189.001]
  • [Cites] Pediatr Blood Cancer. 2005 Nov;45(6):796-801 [15602716.001]
  • [Cites] Rev Med Interne. 2000 Oct;21(10):889-92 [11075397.001]
  • [Cites] Ann Urol (Paris). 2001 Jan;35(1):30-3 [11233317.001]
  • [Cites] J Urol. 1982 Jun;127(6):1177-8 [7087029.001]
  • [Cites] Am J Surg Pathol. 2004 Dec;28(12):1652-4 [15577687.001]
  • [Cites] Hinyokika Kiyo. 2000 Jan;46(1):23-6 [10723660.001]
  • [Cites] Cancer. 1996 Feb 15;77(4):778-84 [8616772.001]
  • [Cites] Nihon Hinyokika Gakkai Zasshi. 2001 Jul;92(5):589-92 [11517572.001]
  • [Cites] Mod Pathol. 1998 Apr;11(4):364-8 [9578087.001]
  • [Cites] Urology. 1976 Jul;8(1):89-91 [941370.001]
  • [Cites] Int Urol Nephrol. 2004;36(2):137-40 [15368679.001]
  • [Cites] Urology. 1997 Aug;50(2):285-8 [9255306.001]
  • [Cites] Korean J Radiol. 2000 Oct-Dec;1(4):219-22 [11752959.001]
  • [Cites] Ann Urol (Paris). 2003 Aug;37(4):147-9 [12951701.001]
  • [Cites] Arch Pathol Lab Med. 2000 Aug;124(8):1209-12 [10923085.001]
  • [Cites] Pediatr Pathol. 1992 Jul-Aug;12 (4):557-61 [1409154.001]
  • [Cites] Cancer. 1990 Sep 15;66(6):1234-41 [2400974.001]
  • [Cites] J Pediatr Surg. 1999 Sep;34(9):1417-9 [10507443.001]
  • (PMID = 16865515.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 37
  •  go-up   go-down


49. Gershtein ES, Levkina NV, Digayeva MA, Laktionov KP, Tereshkina IV, Kushlinsky NE: Matrix metalloproteinases 2, 7, and 9 and tissue inhibitor of metalloproteinases-1 in tumors and serum of patients with ovarian neoplasms. Bull Exp Biol Med; 2010 Oct;149(5):628-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Matrix metalloproteinases 2, 7, and 9 and tissue inhibitor of metalloproteinases-1 in tumors and serum of patients with ovarian neoplasms.
  • The content of matrix metalloproteinases 7 and 9 was significantly increased, while the content of metalloproteinase 2 was reduced in ovarian cancer tissue compared to benign tumors.
  • A significant positive correlation between serum levels of matrix metalloproteinases 7 and 9 and tissue inhibitor of metalloproteinases-1 in patients with ovarian cancer and the size of primary tumor (ultrasound examination) and a positive correlation between these parameters and the concentration of classical ovarian cancer marker CA-125 were demonstrated.
  • [MeSH-major] Biomarkers, Tumor / blood. Matrix Metalloproteinase 2 / blood. Matrix Metalloproteinase 7 / blood. Matrix Metalloproteinase 9 / blood. Ovarian Neoplasms / blood. Tissue Inhibitor of Metalloproteinase-1 / blood

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21165404.001).
  • [ISSN] 1573-8221
  • [Journal-full-title] Bulletin of experimental biology and medicine
  • [ISO-abbreviation] Bull. Exp. Biol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Tissue Inhibitor of Metalloproteinase-1; EC 3.4.24.23 / Matrix Metalloproteinase 7; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


50. Coppens JR, Couldwell WT: Staged use of the transsphenoidal approach to resect superior third ventricular craniopharyngiomas. Minim Invasive Neurosurg; 2010 Feb;53(1):40-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Craniopharyngiomas are benign tumors, usually originating from the infundibulum or tuber cinereum.
  • CASE REPORT: The authors describe the use of an extended transsphenoidal approach as a second-stage operation to resect the intraventricular component of a large craniopharyngioma in an illustrative case.
  • [MeSH-major] Craniopharyngioma / surgery. Craniotomy / methods. Neuroendoscopy / methods. Pituitary Neoplasms / surgery. Sphenoid Sinus / surgery. Third Ventricle / surgery
  • [MeSH-minor] Adult. Decompression, Surgical / methods. Humans. Male. Neoplasm, Residual / diagnosis. Neoplasm, Residual / surgery. Postoperative Complications / diagnosis. Reoperation

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) Georg Thieme Verlag KG Stuttgart . New York.
  • (PMID = 20376745.001).
  • [ISSN] 1439-2291
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


51. Kim JK, Yoo KS, Moon JH, Park KH, Chung YW, Kim KO, Park CH, Hahn T, Park SH, Kim JH, Jeon JY, Kim MJ, Min KS, Park CK: Gallbladder lymphangioma: a case report and review of the literature. World J Gastroenterol; 2007 Jan 14;13(2):320-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lymphangiomas are rare, benign tumors of the lymphatic system, usually present in children aged 5 years and younger.
  • We experienced a case of a 60-year-old man diagnosed with a cystic lymphangioma of the gallbladder, which was successfully resected without any complication.
  • Magnetic resonance imaging and magnetic resonance cholangiopancreatography were very helpful for the diagnosis of the cystic lesion around the gallbladder as were ultrasonography and computed tomography scan.
  • [MeSH-major] Gallbladder Neoplasms / diagnosis. Lymphangioma / diagnosis

  • Genetic Alliance. consumer health - Lymphangioma.
  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Korean Med Sci. 1999 Jun;14(3):257-62 [10402167.001]
  • [Cites] Pancreas. 2001 Jan;22(1):101-2 [11138961.001]
  • [Cites] Chirurg. 2001 Jan;72(1):72-7 [11225460.001]
  • [Cites] Abdom Imaging. 2002 Jan-Feb;27(1):54-7 [11740609.001]
  • [Cites] Surg Endosc. 2003 Oct;17(10):1676 [14702968.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2005;12(5):405-8 [16258810.001]
  • [Cites] Br J Surg. 1989 May;76(5):485-9 [2660949.001]
  • [Cites] Thorax. 1994 Dec;49(12):1267-8 [7878566.001]
  • [Cites] Eur J Radiol. 1995 Mar;19(3):183-7 [7601168.001]
  • [Cites] J Gastroenterol Hepatol. 1995 Nov-Dec;10(6):693-6 [8580416.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1999 Mar;11(3):347-51 [10333211.001]
  • [Cites] Arch Surg. 1985 Nov;120(11):1266-9 [4051731.001]
  • (PMID = 17226918.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 12
  • [Other-IDs] NLM/ PMC4065967
  •  go-up   go-down


52. Ueno T, Sasaki K, Yoshida S, Kajitani N, Satsuka A, Nakamura H, Sakai H: Molecular mechanisms of hyperplasia induction by human papillomavirus E7. Oncogene; 2006 Jul 13;25(30):4155-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infections of human papillomavirus (HPV) induce a variety of benign tumors, such as warts and condylomas.
  • During the process of aberrant cell proliferation, genetic mutations are accumulated in the cells, from which malignant tumor cells arise.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16501608.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / E7 protein, Human papillomavirus type 18; 0 / Oncogene Proteins, Viral; 0 / Retinoblastoma Protein
  •  go-up   go-down


53. Pui MH, Wang Y: Diffusion and magnetization transfer MRI of brain infarct, infection, and tumor in children. Clin Imaging; 2005 May-Jun;29(3):162-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffusion and magnetization transfer MRI of brain infarct, infection, and tumor in children.
  • The purpose of this study was to determine the efficacy of diffusion-weighted imaging (DWI) and magnetization transfer imaging (MTI) in the differential diagnosis of brain infarct, infection, hamartoma, and tumor in 106 children.
  • There was an inverse relationship between ADC and MTR in subacute/chronic infarct, infection, hamartoma, arachnoid cyst, and tumor relative to normal brain parenchyma.
  • DWI and MTI had a complementary role in the differential diagnosis of acute infarct from infection with lower MTR, from hamartoma with higher ADC, and from low-grade gliomas and benign tumors that had higher ADCs and lower MTRs.
  • ADCs increased and MTRs decreased with the duration of infarct and lower tumor grade.
  • [MeSH-major] Brain / pathology. Brain Neoplasms / diagnosis. Central Nervous System Infections / diagnosis. Cerebral Infarction / diagnosis. Diffusion Magnetic Resonance Imaging. Image Processing, Computer-Assisted
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Infant. Infant, Newborn. Male. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15855060.001).
  • [ISSN] 0899-7071
  • [Journal-full-title] Clinical imaging
  • [ISO-abbreviation] Clin Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


54. Schäfer H, Baldus SE, Hölscher AH: Giant adenomas of the rectum: complete resection by transanal endoscopic microsurgery (TEM). Int J Colorectal Dis; 2006 Sep;21(6):533-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Transanal endoscopic microsurgery (TEM) offers an alternative operation method to low-anterior rectum resection in this potentially benign tumor situation.
  • A total of 33 patients met the criteria and were analyzed for postoperative complications, histology, and incidence of occult adenocarcinoma; residual tumor status; and tumor recurrence.
  • The residual adenoma status was 18% (n=6), especially in patients with tumors sizes more than 30 cm2.
  • In case of adenoma recurrence (n=4, 12%), a conventional transanal excision (Parks) was applicable, as these tumors were mostly located within the suture-line region of the lower rectum.
  • In case of advanced tumors (1xpT2, 1xpT3), anterior rectum resection was carried out, whereas for the early tumors (2xpT1 low risk, 1x1 pTis), no further therapy was added.
  • CONCLUSION: TEM is an alternative method for the resection of large benign rectal tumors located in the mid- and upper third of the rectum.
  • [MeSH-major] Adenoma / surgery. Colonoscopy / methods. Microsurgery. Rectal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg. 1987 Jan;153(1):41-7 [3799891.001]
  • [Cites] Dis Colon Rectum. 2003 Mar;46(3):340-8 [12626909.001]
  • [Cites] Dis Colon Rectum. 2005 May;48(5):1021-6 [15789125.001]
  • [Cites] Ann Surg. 2004 Aug;240(2):255-9 [15273549.001]
  • [Cites] Dis Colon Rectum. 1995 Mar;38(3):233-8 [7882783.001]
  • [Cites] Surg Endosc. 1995 Oct;9(10):1106-12 [8553213.001]
  • [Cites] Int J Colorectal Dis. 2003 Mar;18(2):131-5 [12548415.001]
  • [Cites] Proc R Soc Med. 1974 Jun;67(6 Pt 1):451-7 [4853754.001]
  • [Cites] Dis Colon Rectum. 2004 Jan;47(1):86-9 [14702647.001]
  • [Cites] Endoscopy. 2003 Aug;35(8):S41-4 [12929053.001]
  • [Cites] Curr Top Pathol. 1990;81:277-93 [2407443.001]
  • [Cites] Am Surg. 1998 Dec;64(12):1170-3 [9843338.001]
  • [Cites] Br J Surg. 1973 Sep;60(9):688-95 [4582241.001]
  • [Cites] Am J Surg. 1997 May;173(5):383-5 [9168071.001]
  • [Cites] Ann Surg. 1988 Jan;207(1):65-71 [3337563.001]
  • [Cites] Am J Surg. 1976 Feb;131(2):185-91 [175719.001]
  • [Cites] Am J Surg. 1975 Dec;130(6):729-32 [1200290.001]
  • [Cites] Chirurg. 2005 Apr;76(4):379-84 [15502890.001]
  • [Cites] Gastrointest Endosc. 1996 Mar;43(3):183-8 [8857131.001]
  • [Cites] Gastrointest Endosc. 1984 Feb;30(1):18-20 [6706083.001]
  • [Cites] Surg Clin North Am. 1997 Feb;77(1):229-39 [9092112.001]
  • [Cites] Am J Surg. 1992 Jan;163(1):63-9; discussion 69-70 [1733375.001]
  • (PMID = 16133003.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


55. De Bie G, Legrand A, Mahillon V, Lemort M, Gilles A, Saussez S: Schwannoma of the accessory phrenic nerve. Am J Otolaryngol; 2007 Sep-Oct;28(5):357-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Otolaryngologists are frequently confronted with the management of cervical tumors.
  • Neurogenic tumors concern, especially, the cranial, sympathetic, or peripheral nerve sheathes.
  • These tumors are benign and grow slowly.
  • We describe the first case of a cervical schwannoma involving the accessory phrenic nerve.
  • [MeSH-major] Neurilemmoma / surgery. Peripheral Nervous System Neoplasms / surgery. Phrenic Nerve
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17826542.001).
  • [ISSN] 0196-0709
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Peltz M, Estrera AS: Resection of a giant esophageal fibrovascular polyp. Ann Thorac Surg; 2010 Sep;90(3):1017-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resection of a giant esophageal fibrovascular polyp.
  • Fibrovascular polyps of the esophagus are rare benign neoplasms of the esophagus.
  • They frequently reach giant proportions before patients develop symptoms and a diagnosis is made.
  • We report a case of a giant fibrovascular polyp in a 79-year-old man that was detected incidentally.
  • [MeSH-major] Esophageal Neoplasms / surgery. Polyps / surgery

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20732542.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


57. Ahmed S, Burney I, Sawhney S, Al-Moundhri MS: Gastric Adenocarcinoma in Association with Tuberous Sclerosis: Case report. Sultan Qaboos Univ Med J; 2009 Apr;9(1):75-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tuberous sclerosis is an autosomal dominant disorder which presents with a constellation of signs including benign tumours in the brain and in other vital organs such as the kidneys, heart, eyes, lungs, and skin.
  • A combination of symptoms may include seizures, developmental delay, behavioural problems, skin abnormalities, and lung and kidney disease.
  • These proteins act as tumour growth suppressor agents that regulate cell proliferation and differentiation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Korean Med Sci. 2000 Aug;15(4):467-70 [10983700.001]
  • [Cites] Hum Genet. 2000 Oct;107(4):350-6 [11129334.001]
  • [Cites] Br J Cancer. 2001 Oct 19;85(8):1226-30 [11710839.001]
  • [Cites] J Urol. 2003 May;169(5):1635-42 [12686801.001]
  • [Cites] Chest. 1985 Sep;88(3):473-5 [4028861.001]
  • (PMID = 21509279.001).
  • [ISSN] 2075-051X
  • [Journal-full-title] Sultan Qaboos University medical journal
  • [ISO-abbreviation] Sultan Qaboos Univ Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Oman
  • [Other-IDs] NLM/ PMC3074756
  • [Keywords] NOTNLM ; Case report / Gastric cancer / Hamartoma / Lymphangiomyomatosis / Mucinous adenocarcinoma / Oman / Tuberous sclerosis
  •  go-up   go-down


58. Hasturk A, Tun K, Guvenc Y, Kaptanoglu E: Cranial ossifying fibroma causing visual disorder. J Craniofac Surg; 2010 May;21(3):768-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cranial ossifying fibroma causing visual disorder.
  • Fibrous lesions of the head and the maxillofacial region are generally slow-developing benign tumors that may aggressively take course in clinical terms.
  • Difficulties in the diagnosis, classification, and treatment make this entity complex for several years.
  • These tumors are frequently seen among children and young adults.
  • The maxilla and the mandibula are the 2 most common sites that the tumor originates.
  • Accompanied by literature findings, it has been underlined that, as well as with the pathologic criteria, clinical features and radiologic images should be evaluated together for a specific diagnosis in fibrous lesions.
  • [MeSH-major] Fibroma, Ossifying / complications. Skull Neoplasms / complications. Vision Disorders / etiology
  • [MeSH-minor] Craniotomy. Decompression, Surgical. Diagnosis, Differential. Humans. Male. Middle Aged. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Vision Impairment and Blindness.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20485044.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Bornemann A, Koitschev A: A 57-year-old female with a benign tumor in the ethmoid sinus. Brain Pathol; 2006 Oct;16(4):335-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A 57-year-old female with a benign tumor in the ethmoid sinus.
  • [MeSH-major] Ethmoid Sinus / pathology. Neurocytoma / pathology. Paranasal Sinus Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Immunohistochemistry. Middle Aged. Mucocele / pathology. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17107604.001).
  • [ISSN] 1015-6305
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Switzerland
  •  go-up   go-down


60. Chang W, Oiseth SJ, Orentlicher R, Agarwal G, Yahr LJ, Cayten CG: Bilateral sclerosing stromal tumor of the ovaries in a premenarchal girl. Gynecol Oncol; 2006 May;101(2):342-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral sclerosing stromal tumor of the ovaries in a premenarchal girl.
  • BACKGROUND: Sclerosing stromal tumor of the ovary is a rare benign neoplasm that is usually unilateral in menstruating women with a mean age of 27.
  • CASE: An 11-year-old girl presented with asymptomatic bilateral sclerosing stromal tumor of the ovaries prior to menarche.
  • CONCLUSION: We herein report a unique case of bilateral sclerosing stromal tumor of the ovaries arising in a premenarchal girl.
  • [MeSH-major] Ovarian Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16403568.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Kwon H, Kim HY, Jung SN, Sohn WI, Yoo G: Extraskeletal chondroma in the auricle. J Craniofac Surg; 2010 Nov;21(6):1990-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Extraskeletal chondroma is a rare benign tumor that develops in soft tissues, and histologically, it is a lobulated nodule surrounded by a fibrous capsule, and the inside consists of mature cartilage cells and diffuse hyalinized matrix.
  • [MeSH-major] Chondroma / diagnosis. Ear Auricle / pathology. Ear Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Chondroma.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for extraskeletal chondroma .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21119479.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


62. Telem DA, Nguyen SQ, Chin EH, Weber K, Divino CM: Laparoscopic resection of giant adrenal cavernous hemangioma. JSLS; 2009 Apr-Jun;13(2):260-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Large adrenal tumors were initially believed to be a relative contraindication to laparoscopic adrenalectomy.
  • METHODS: Here we discuss the case of a 42-year-old female with a 12-cm adrenal mass.
  • RESULTS: The patient underwent successful laparoscopic resection, and pathology revealed a cavernous hemangioma, a rare benign tumor of the adrenal gland.

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 1993 May-Jun;17(3):506-7 [8491927.001]
  • [Cites] Acta Radiol. 1995 Nov;36(6):659-61 [8519580.001]
  • [Cites] J Urol. 1996 Feb;155(2):638 [8558680.001]
  • [Cites] J Urol. 1992 Jan;147(1):110-2 [1729495.001]
  • [Cites] Curr Opin Urol. 1999 May;9(3):213-8 [10726093.001]
  • [Cites] Int J Urol. 2001 Aug;8(8):457-8 [11555014.001]
  • [Cites] Surgery. 1989 May;105(5):674-81 [2650008.001]
  • [Cites] J Urol. 1955 Nov;74(5):573-7 [13272266.001]
  • (PMID = 19660229.001).
  • [ISSN] 1086-8089
  • [Journal-full-title] JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • [ISO-abbreviation] JSLS
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3015926
  •  go-up   go-down


63. Kutay V, Tuncer M, Harman M, Ekim H, Yakut C: Intracardiac extension of intravenous leiomyoma. Tex Heart Inst J; 2005;32(2):232-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intravenous leiomyoma with intracaval and intracardiac extension is a rare benign neoplasm affecting women.
  • The correct diagnosis was made intraoperatively, after resection of the intracardiac extension of the tumor, which was 28 cm in length.
  • At the 2nd stage of the operation, a right common iliac venotomy enabled the removal of all residual tumor from the inferior vena cava.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2002 Feb;26(2):232-6 [11812945.001]
  • [Cites] Clin Radiol. 2002 Nov;57(11):1037-40 [12409117.001]
  • [Cites] Gynecol Oncol. 2003 Apr;89(1):175-80 [12694674.001]
  • [Cites] J Vasc Surg. 2004 Feb;39(2):465-9 [14743155.001]
  • [Cites] J Vasc Surg. 2000 May;31(5):1046-51 [10805899.001]
  • [Cites] Cancer. 1975 Dec;36(6):2164-78 [1203870.001]
  • [Cites] N Engl J Med. 1980 Oct 30;303(18):1043-4 [7421892.001]
  • [Cites] Cardiovasc Surg. 1999 Oct;7(6):661-4 [10519678.001]
  • [Cites] Ann Thorac Surg. 2004 Jul;78(1):330-2 [15223460.001]
  • (PMID = 16107124.001).
  • [ISSN] 0730-2347
  • [Journal-full-title] Texas Heart Institute journal
  • [ISO-abbreviation] Tex Heart Inst J
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1163482
  •  go-up   go-down


64. Martínez De Pablo MI, Iranzo P, Mascaró JM, Llambrich A, Baradad M, Herrero C: Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol; 2005;85(3):233-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.
  • Paraneoplastic pemphigus is a life-threatening autoimmune bullous disease associated with neoplasia, generally of lymphoid origin.
  • These cases were generally associated with benign neoplasms.
  • We report here the case of a patient with paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma who had a surprisingly good response to systemic corticosteroids and remains free of lesions more than 3 years later despite progression of her neoplasm.
  • [MeSH-major] Lymphoma, B-Cell / diagnosis. Paraneoplastic Syndromes / diagnosis. Pemphigus / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Drug Administration Schedule. Female. Glucocorticoids / administration & dosage. Humans. Oral Ulcer / pathology. Prednisone / administration & dosage

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • Genetic Alliance. consumer health - Pemphigus.
  • Genetic Alliance. consumer health - Non-Hodgkin Lymphoma.
  • MedlinePlus Health Information. consumer health - Pemphigus.
  • Hazardous Substances Data Bank. PREDNISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16040408.001).
  • [ISSN] 0001-5555
  • [Journal-full-title] Acta dermato-venereologica
  • [ISO-abbreviation] Acta Derm. Venereol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Glucocorticoids; VB0R961HZT / Prednisone
  •  go-up   go-down


65. Perrini P, Caniglia M, Pieroni M, Castagna M, Parenti GF: Malignant transformation of intramedullary melanocytoma: case report. Neurosurgery; 2010 Sep;67(3):E867-9; discussion E869
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Meningeal melanocytomas are low-grade primary melanocytic tumors with benign histological features and a favorable clinical prognosis.
  • Two years later, the tumor recurred locally, and the patient underwent additional surgery to remove the intramedullary mass.
  • The histological findings of the tumor were consistent with an intramedullary malignant melanoma.
  • CONCLUSION: The malignant transformation of melanocytic tumors of the central nervous system may occur years after surgical treatment, and its incidence remains unknown.
  • Emphasis should be placed on the importance of careful and continued follow-up monitoring of the tumor.
  • [MeSH-major] Cell Transformation, Neoplastic / pathology. Melanoma / pathology. Meningeal Neoplasms / pathology. Nevus, Pigmented / pathology. Spinal Cord Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20657325.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Quaia E, Palumbo A, Rossi S, Degobbis F, Cernic S, Tona G, Cova M: Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection. AJR Am J Roentgenol; 2006 Jun;186(6):1560-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection.
  • OBJECTIVE: The objective of our study was to compare diagnostic performance of visual and quantitative analysis for the characterization of liver tumors insonated at low transmit power after microbubble contrast agent injection.
  • SUBJECTS AND METHODS: This series comprised 166 liver tumors (1-5 cm in diameter) in 166 patients (99 men, 67 women; mean age +/- SD, 58 +/- 11 years) scanned at low transmit power (mechanical index: 0.1-0.14) after sulfur hexafluoride-filled microbubble injection.
  • Digital cine clips recorded at the arterial phase (10-40 sec after contrast injection) and late phase (100-300 sec) were analyzed to characterize liver tumors as benign or malignant.
  • Visual analysis was performed by three independent blinded reviewers who evaluated enhancement patterns at the arterial phase and subjective tumor conspicuity at the late phase.
  • Quantitative analysis of videotape intensity (VI: gray-scale levels, 0-255) was performed to calculate objective tumor conspicuity at the late phase: (VI(tumor) - VI(liver)) / VI(liver).
  • RESULTS: Characteristic enhancement patterns were observed in malignant tumors (peripheral rimlike) and benign tumors (peripheral nodular or central and spoke-wheel-shaped).
  • Malignant (n = 95) versus benign (n = 71) tumors differed for subjective (median value: -1 vs 1, respectively) and objective conspicuity at the late phase (-0.6 vs 0.15, respectively; p = 0.001, Mann-Whitney U test) due to persistent microbubble uptake in benign tumors.
  • Diagnostic performance of visual (odds ratio: reviewer 1 = 4.28, reviewer 2 = 10.18, reviewer 3 = 9.56) and quantitative (odds ratio: 89.33) analyses differed significantly in the characterization of liver tumors (p = 0.01, chi-square test).
  • CONCLUSION: Quantitative analysis revealed higher diagnostic performance than visual analysis to characterize liver tumors insonated at low transmit power after microbubble contrast agent injection.
  • [MeSH-major] Contrast Media / administration & dosage. Liver Neoplasms / ultrasonography. Microbubbles

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16714644.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


67. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M: Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int; 2009 May;59(5):300-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.
  • Tumor-associated macrophages (TAM) are known to possess the immunosuppressive M2 macrophage phenotype.
  • They contribute to tumor growth, invasion, and metastasis by producing various mediators.
  • Macrophages, especially M2 polarized macrophages, preferentially express CD163 and CD204, but few studies have investigated macrophage phenotypes in human ovarian tumors.
  • The purpose of the present study was therefore to present results on macrophage differentiation in human ovarian serous and mucinous epithelial tumors.
  • The method focused on immunostaining of paraffin-embedded tumor samples.
  • Almost all macrophages infiltrating tumor tissues expressed CD163 and CD204, indicating the phenotypic shift toward M2 macrophage.
  • The numbers of CD68-positive macrophages as well as of CD163- and CD204-positive macrophages in borderline and malignant tumors were significantly higher than in benign tumors.
  • CSF-1 expression in malignant tumor cells was significantly higher than that in benign tumor cells and correlated with histological malignancy.
  • These results suggest that CSF-1 derived from tumor tissues induces macrophages to shift toward the M2 phenotype, which is considered to promote tumor growth.
  • [MeSH-major] Cystadenocarcinoma, Mucinous / immunology. Cystadenocarcinoma, Serous / immunology. Macrophage Colony-Stimulating Factor / biosynthesis. Macrophages / immunology. Ovarian Neoplasms / immunology
  • [MeSH-minor] Adult. Aged. Antigens, CD / immunology. Antigens, CD / metabolism. Antigens, Differentiation, Myelomonocytic / immunology. Antigens, Differentiation, Myelomonocytic / metabolism. Cell Differentiation / immunology. Female. Humans. Immunohistochemistry. Middle Aged. Neoplasm Invasiveness / immunology. Phenotype. Receptors, Cell Surface / immunology. Receptors, Cell Surface / metabolism. Scavenger Receptors, Class A / immunology. Scavenger Receptors, Class A / metabolism

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19432671.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD163 antigen; 0 / MSR1 protein, human; 0 / Receptors, Cell Surface; 0 / Scavenger Receptors, Class A; 81627-83-0 / Macrophage Colony-Stimulating Factor
  •  go-up   go-down


68. Ko JM, Jung JI, Park SH, Lee KY, Chung MH, Ahn MI, Kim KJ, Choi YW, Hahn ST: Benign tumors of the tracheobronchial tree: CT-pathologic correlation. AJR Am J Roentgenol; 2006 May;186(5):1304-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign tumors of the tracheobronchial tree: CT-pathologic correlation.
  • OBJECTIVE: The purpose of this essay is to illustrate the CT findings of variable benign tumors of the tracheobronchial tree and to correlate the CT and pathologic findings in 17 patients.
  • CONCLUSION: The tracheal tumors were eccentric, well-defined, polypoid masses in all cases.
  • The endobronchial tumors were masses confined within the bronchus in all cases, and atelectasis or pneumonia of the distal parenchyma was frequently associated.
  • The other benign tumors were low-attenuating, soft-tissue-density masses without characteristic findings on CT scans.
  • [MeSH-major] Bronchial Neoplasms / pathology. Bronchial Neoplasms / radiography. Neoplasms, Multiple Primary / pathology. Neoplasms, Multiple Primary / radiography. Tomography, X-Ray Computed. Tracheal Neoplasms / pathology. Tracheal Neoplasms / radiography

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16632723.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Meccariello R, Damiano I, Pelosio L, Rizzo GM, Ansalone M, D'Aniello F: [Biliodigestive anastomosis: case series and technical notes]. Minerva Chir; 2006 Feb;61(1):31-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Anastomosi bilio-digestive. Casistica e note di tecnica.
  • Thirty biliodigestive anastomose have been performed both for neoplastic disease and for benign lesions.
  • RESULTS: The biliodigestive anastomosis has been performed with the Blumgart's technique both for benign and malignant tumors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16568020.001).
  • [ISSN] 0026-4733
  • [Journal-full-title] Minerva chirurgica
  • [ISO-abbreviation] Minerva Chir
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


70. Sharma U, Danishad KK, Seenu V, Jagannathan NR: Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed; 2009 Jan;22(1):104-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
  • Measurements of tumor apparent diffusion coefficient (ADC), volume and diameter in assessing the response of patients with locally advanced breast cancer (LABC) (n = 56) undergoing neoadjuvant chemotherapy (NACT) at four time periods (before treatment and after three cycles of NACT) were carried out at 1.5 T using diffusion-weighted imaging (DWI) and MRI.
  • Ten benign tumors and 15 controls were also investigated.
  • The MR tumor response was compared with the clinical response.
  • Mean ADC before treatment of malignant breast tissue was significantly lower than that of controls, disease-free contralateral tissue of the patients, and benign lesions, and gradually increased during the course of NACT.
  • Analysis of the percentage change in ADC, volume and diameter after each cycle of NACT between clinical responders and non-responders showed that the change in ADC after the first cycle was statistically significant compared with volume and diameter, indicating its potential in assessing early response.
  • After the third cycle, the sensitivity for differentiating responders from non-responders was 89% for volume and diameter and 68% for ADC, and the respective specificities were 50%, 70% and 100%.
  • A cut-off value of ADC was also calculated using receiver operator characteristics analysis to discriminate between normal, benign and malignant breast tissue.
  • Similarly, a cut-off value for ADC, volume and diameter was obtained after the second and third cycles of NACT to predict tumor response.
  • The results show that ADC is more useful for predicting early tumor response to NACT than morphological variables, suggesting its potential in effective treatment management.
  • [MeSH-major] Breast Neoplasms / drug therapy. Breast Neoplasms / pathology. Diffusion Magnetic Resonance Imaging. Neoadjuvant Therapy

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18384182.001).
  • [ISSN] 0952-3480
  • [Journal-full-title] NMR in biomedicine
  • [ISO-abbreviation] NMR Biomed
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


71. Pais SA, Attasaranya S, Leblanc JK, Sherman S, Schmidt CM, DeWitt J: Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol; 2007 Apr;5(4):489-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology.
  • BACKGROUND & AIMS: Intraductal papillary mucinous neoplasms (IPMNs) are precancerous tumors characterized by dilation of the main pancreatic duct, its side branches, or both.
  • The purpose of this study was to evaluate the role of endoscopic ultrasound (EUS) in differentiating benign and malignant IPMNs.
  • Malignancy was defined as the presence of invasive carcinoma; all other neoplasms were considered benign.
  • RESULTS: Seventy-four patients (38 male; mean age, 65 years) with 21 (28%) malignant and 53 (72%) benign IPMNs were identified.
  • Compared with benign tumors, patients with malignant IPMNs were more likely to be older (P = .011), present with jaundice (P = .03) or weight loss (P = .03), and have EUS features of a dilated main pancreatic duct (P = .0001), solid lesion (P = .0001), pancreatic ductal filling defects (P = .03), or thickened septa within any cyst (P = .02).
  • The sensitivity, specificity, and accuracy of EUS-FNA for the diagnosis of malignancy were 75% (95% confidence interval [CI], 53%-89%), 91% (95% CI, 79%-97%), and 86% (95% CI, 76%-93%), respectively.
  • CONCLUSIONS: Older age, jaundice and weight loss, and EUS features of a solid lesion, dilated main pancreatic duct, ductal filling defects, and thickened septa are predictive of malignancy in patients with IPMNs.
  • EUS-FNA cytology is helpful, but cyst fluid CEA and CA 19-9 are of limited value to differentiate malignant from benign IPMNs.
  • [MeSH-major] Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Pancreatic Ductal / ultrasonography. Endosonography / methods. Pancreatic Neoplasms / pathology. Pancreatic Neoplasms / ultrasonography

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17350894.001).
  • [ISSN] 1542-7714
  • [Journal-full-title] Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • [ISO-abbreviation] Clin. Gastroenterol. Hepatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Kobayashi K, Fukata S, Miyauchi A: Diagnosis of follicular carcinoma of the thyroid: role of sonography in preoperative diagnosis of follicular nodules. J Med Ultrason (2001); 2005 Dec;32(4):153-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis of follicular carcinoma of the thyroid: role of sonography in preoperative diagnosis of follicular nodules.
  • Nine hundred and ten consecutive patients with follicular nodules were pathologically classified as having follicular carcinoma (109 patients) or benign tumor (811 patients).
  • Benign tumors included follicular adenoma (237 patients) and adenomatous thyroid nodules (574 patients).
  • A case-control study was performed for follicular carcinomas and benign tumors.
  • "Thyroglobulin 1000 ng/ml≦", "cytology class 3≦", and a "solid pattern", "low-echoic level of internal echo", and "jagged borders" of follicular carcinomas were found to be significantly higher than those of benign tumors.
  • The sensitivities of a solid pattern (79.8%) and a low-echoic level (75.2%) were found to be relatively higher than those of other features and findings.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thyroid. 1998 May;8(5):377-83 [9623727.001]
  • [Cites] Thyroid. 2003 May;13(5):479-84 [12855015.001]
  • [Cites] Thyroid. 2000 Aug;10(8):709-12 [11014317.001]
  • [Cites] World J Surg. 1994 Jul-Aug;18(4):495-8; discussion 499 [7725734.001]
  • [Cites] J Clin Ultrasound. 1995 Mar-Apr;23 (3):179-84 [7730464.001]
  • [Cites] Thyroid. 1998 Nov;8(11):989-95 [9848711.001]
  • [Cites] Mayo Clin Proc. 1997 Oct;72(10):913-6 [9379692.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Aug;88(8):3668-73 [12915653.001]
  • [Cites] Acta Cytol. 1997 May-Jun;41(3):687-91 [9167684.001]
  • [Cites] Ann Intern Med. 1993 Feb 15;118(4):282-9 [8420446.001]
  • [Cites] Radiology. 1985 Apr;155(1):187-91 [3883413.001]
  • [Cites] JAMA. 1983 Jun 3;249(21):2941-4 [6341650.001]
  • [Cites] Eur J Surg Oncol. 1998 Dec;24(6):553-7 [9870733.001]
  • [Cites] Arch Intern Med. 1990 Jul;150(7):1422-7 [2196027.001]
  • (PMID = 27277482.001).
  • [ISSN] 1346-4523
  • [Journal-full-title] Journal of medical ultrasonics (2001)
  • [ISO-abbreviation] J Med Ultrason (2001)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Keywords] NOTNLM ; cytology / follicular carcinoma / sonography / thyroglobulin / thyroid
  •  go-up   go-down


73. Pandya KA, Radke F: Benign skin lesions: lipomas, epidermal inclusion cysts, muscle and nerve biopsies. Surg Clin North Am; 2009 Jun;89(3):677-87
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign skin lesions: lipomas, epidermal inclusion cysts, muscle and nerve biopsies.
  • Lipomas are benign skin tumors composed of mature fat cells and are the most common subcutaneous tumors.
  • The diagnosis, pathology, and treatment of benign tumors, and other commonly associated tumors that may require a more substantial workup and operative intervention, are discussed.
  • Muscle and nerve biopsies are used for the diagnosis of a variety of medical problems.
  • Although the procedures are straightforward, there are important technical issues to assist in getting the best specimen to avoid confounding disease diagnosis.
  • [MeSH-major] Biopsy / methods. Cysts / pathology. Lipoma / pathology. Muscle, Skeletal / pathology. Peripheral Nerves / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Biopsy.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19465204.001).
  • [ISSN] 1558-3171
  • [Journal-full-title] The Surgical clinics of North America
  • [ISO-abbreviation] Surg. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 36
  •  go-up   go-down


74. Tincani AJ, Araújo PP, DelNegro A, Altemani A, Martins AS: Childhood maxillary myxoma: case report and review of management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov;104(5):e5-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myxomas are benign neoplasms of uncertain origin and etiology.
  • More recently, in 1995, Takahashi et al., through extensive research confirmed the fibroblastic and histiocytic origin of the tumor.
  • [MeSH-major] Facial Asymmetry / surgery. Maxillary Neoplasms / surgery. Myxoma / surgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17764985.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Ceylan A, Celenk F, Poyraz A, Uslu S: Pleomorphic adenoma of the nasal columella. Pathol Res Pract; 2008;204(4):273-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pleomorphic adenoma (mixed tumor) is the most common benign neoplasm of the salivary glands.
  • Irrespective of the site where the lesion originates, its preferred treatment should be surgery.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Neoplasm Recurrence, Local. Neoplasm Seeding. Nose Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18295980.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


76. Akcali Y, Karahan OI, Kahriman G, Ceyran H, Balkanli S: Angiomyolipoma with cavoatrial extension. Eur Urol; 2006 Sep;50(3):605-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathologic evaluation revealed a tumor consisting of mature adipose tissue, smooth muscle and vessels consistent with angiomyolipoma.
  • Our case reminds us of the rare possibility that angiomyolipoma, which is classified as a benign tumor, may invade the inferior vena cava or right atrium.
  • [MeSH-major] Angiomyolipoma / diagnosis. Heart Atria / pathology. Heart Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16828222.001).
  • [ISSN] 0302-2838
  • [Journal-full-title] European urology
  • [ISO-abbreviation] Eur. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


77. Kamat G, Yelikar B, Shettar S, Karigoudar MH: Pigmented trichoblastoma with sebaceous hyperplasia. Indian J Dermatol Venereol Leprol; 2009 Sep-Oct;75(5):506-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Trichoblastoma is a rare benign trichogenic tumour with epithelial and mesenchymal components recapitulating the germinal hair bulb and associated mesenchyme.
  • Microscopy of tumour revealed nodular tumour spanning the entire dermis with collection of mesenchymal cells resembling follicular papilla.
  • There is a need for differentiation of this tumor which is benign, from other pigmented tumors having basaloid arrangement of cells such as basal cell carcinoma.
  • [MeSH-major] Neoplasms, Glandular and Epithelial / diagnosis. Sebaceous Gland Neoplasms / diagnosis
  • [MeSH-minor] Humans. Hyperplasia. Male. Middle Aged. Skin Neoplasms / complications. Skin Neoplasms / diagnosis. Skin Neoplasms / pathology. Skin Pigmentation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19736433.001).
  • [ISSN] 0973-3922
  • [Journal-full-title] Indian journal of dermatology, venereology and leprology
  • [ISO-abbreviation] Indian J Dermatol Venereol Leprol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


78. Wang Q, Wang S, Zhou S, Lu Y: [Clinical analysis of the primary nasal septum mass in 253 cases]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan;23(2):60-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSION: If the diagnosis was confirmed, the effect of the surgical treatment for the nasal septum benign tumor is satisfactory.
  • Follow-up should be done in cases with malignant tendency and malignant tumors.
  • [MeSH-major] Nasal Septum / pathology. Nose Neoplasms

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19452708.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


79. Ramana RK, Darki A, Havens M, Wojcik E, Brylka D, Singh MM, Leya F: Lipotamous cardiac disorders: two unsual cases and a review of the literature. J Invasive Cardiol; 2009 Apr;21(4):E65-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumors involving the heart and surrounding cardiac structures may be benign or malignant and can be classified as primary versus secondary in etiology.
  • Primary cardiac tumors are rare lesions and the vast majority of these are benign neoplasms.
  • [MeSH-major] Cardiomyopathy, Hypertrophic / diagnosis. Heart Diseases / diagnosis. Heart Neoplasms / diagnosis. Lipomatosis / diagnosis

  • MedlinePlus Health Information. consumer health - Heart Disease in Women.
  • MedlinePlus Health Information. consumer health - Heart Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19342764.001).
  • [ISSN] 1557-2501
  • [Journal-full-title] The Journal of invasive cardiology
  • [ISO-abbreviation] J Invasive Cardiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human
  • [Number-of-references] 36
  •  go-up   go-down


80. Ang WM, Yates P, Robbins P, Wood D: Recurrent benign solitary intraosseous schwannoma of the tibia. Orthopedics; 2008 Feb;31(2):176
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent benign solitary intraosseous schwannoma of the tibia.
  • Schwannomas (neurilemmomas) are benign neoplasms composed of well-differentiated Schwann cells and are usually found in the soft tissues.
  • The occurrence of schwannomas in bone is rare, accounting for less than 0.2% of primary bone tumors.
  • We report the first case of a recurrent benign solitary intraosseous schwannoma of the tibia, and detail the clinical, radiological and histological findings.
  • [MeSH-major] Bone Neoplasms / radiography. Bone Neoplasms / surgery. Neoplasm Recurrence, Local / radiography. Neoplasm Recurrence, Local / surgery. Neurilemmoma / radiography. Neurilemmoma / surgery. Tibia / surgery

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19292192.001).
  • [ISSN] 0147-7447
  • [Journal-full-title] Orthopedics
  • [ISO-abbreviation] Orthopedics
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Kim HK, Choi YH, Cho YH, Sohn YS, Kim HJ: Intercostal neuralgia caused by a parosteal lipoma of the rib. Ann Thorac Surg; 2006 May;81(5):1901-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Parosteal lipoma is an extremely rare benign tumor that is composed mainly of mature adipose tissue, and it has an intimate relationship to the underlying periosteal bone.
  • Although parosteal lipoma is asymptomatic, motor and sensory function deficits have been reported that were caused by the tumor compressing the neuromuscular bundles in the proximal forearm and the sciatic nerve.
  • [MeSH-major] Bone Neoplasms / complications. Chest Pain / etiology. Lipoma / complications. Periosteum / pathology. Ribs

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Chest Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16631705.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


82. Theodorou DJ, Theodorou SJ, Sartoris DJ: An imaging overview of primary tumors of the spine: Part 1. Benign tumors. Clin Imaging; 2008 May-Jun;32(3):196-203
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An imaging overview of primary tumors of the spine: Part 1. Benign tumors.
  • Primary benign tumors of the spine are uncommon, with intriguing clinical and imaging manifestations.
  • Presentation of a solitary lesion of the spine can pose a difficult diagnostic dilemma.
  • We revisit the imaging characteristics of benign spinal tumors, realizing that a concise and handy overview of disease findings can prove useful for radiologists and clinicians engaged in routine practice.
  • This review may serve as a comprehensive imaging tool summarizing key manifestations of disease.
  • A broad range of benign spinal tumors is illustrated, with emphasis on the imaging features that may allow prospective diagnosis in most cases.
  • [MeSH-major] Diagnostic Imaging / methods. Image Enhancement. Spinal Neoplasms / pathology. Spinal Neoplasms / radiography
  • [MeSH-minor] Adult. Contrast Media / pharmacology. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging / methods. Male. Middle Aged. Neoplasm Staging. Sensitivity and Specificity. Spinal Diseases / pathology. Spinal Diseases / radiography. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18502347.001).
  • [ISSN] 1873-4499
  • [Journal-full-title] Clinical imaging
  • [ISO-abbreviation] Clin Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 17
  •  go-up   go-down


83. Dallaudiere B, Benayoun Y, Boncoeur-Martel M, Robert P, Adenis J, Maubon A: [Imaging features of cavernous hemangiomas of the orbit]. J Radiol; 2009 Sep;90(9 Pt 1):1039-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cavernous hemangioma is the most frequent benign tumor of the orbit.
  • The clinical presentation is that of a slowly progressive intra-orbital mass with variable degree of exophthalmos.
  • CT typically demonstrates the presence of a well defined oval or rounded shaped mass but MRI provides superior evaluation of the orbit.
  • The tumor is intra-conal in 80% of cases and usually shows T1W hypo-isointensity, T2W hyperintensity and heterogeneous contrast enhancement that becomes more homogeneous on delayed imaging (5 minutes).
  • [MeSH-major] Hemangioma, Cavernous / diagnosis. Orbital Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19752807.001).
  • [ISSN] 0221-0363
  • [Journal-full-title] Journal de radiologie
  • [ISO-abbreviation] J Radiol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


84. Khandekar MM, Kavatkar AN, Patankar SA, Bagwan IB, Puranik SC, Deshmukh SD: FNAC of salivary gland lesions with histopathological correlation. Indian J Otolaryngol Head Neck Surg; 2006 Jul;58(3):246-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To evaluate utility of FNAC in salivary gland lesions.Back ground: Salivary gland lesions form about 2-6.5% of all head and neck neoplasms in adults.
  • They are easily accessible for FNAC (Fine Needle Aspiration Cytology) and risks of fistula formation or tumour implantation are low compared surgical biopsy.
  • Also, cytology can provide a distinction between asalivary and non salivary lesion, benign and malignant lesions so also specific and non specific inflammation.
  • RESULTS: 80% of the lesions were neoplastic (61% benign, 31% malignant) and 20% were neoplastic.
  • Pleomorphic adenoma was the most frequent benign neoplasm while mucoepidermoid carcinoma was the most frequent malignant lesion.
  • Among the non neoplastic lesions, the maximum number of cases were of chronic sialadentis.
  • In the present study, FNAC has a sensitivity of 94.54% and specificity of 80.95% for neoplastic lesions.
  • CONCLUSIONS: FNAC was found to be a useful diagnostic tool in the evaluation of salivary gland lesions because of its simplicity, excellent patient compliance and rapid diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23120304.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450424
  • [Keywords] NOTNLM ; FNAC / Salivary Gland / Salivary Gland Tumours
  •  go-up   go-down


85. Belizon A, Balik E, Horst PK, Shantha Kumara HM, Nasar A, Whelan RL: Platelet-derived growth factor (subtype BB) is elevated in patients with colorectal carcinoma. Dis Colon Rectum; 2009 Jun;52(6):1166-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Platelet-derived growth factor-BB plays a role in the development of vascular and lymphatic vessels in tumors.
  • Preoperative colorectal cancer platelet-derived growth factor-BB levels were higher (1,771.1 pg/ml; confidence intervals, 1,429-2,065) than in the benign neoplasm group (1083 pg/ml; confidence intervals, 933-1,192, P < 0.001).
  • In patients with colorectal cancer, a direct relationship was noted between platelet-derived growth factor-BB levels and disease severity.
  • CONCLUSION: Platelet-derived growth factor-BB levels were greater in patients with colorectal cancer (vs. patients with adenoma) and rose with increasing disease severity.
  • [MeSH-major] Adenoma / blood. Colorectal Neoplasms / blood. Platelet-Derived Growth Factor / metabolism
  • [MeSH-minor] Aged. Biomarkers, Tumor / blood. Chi-Square Distribution. Enzyme-Linked Immunosorbent Assay. Female. Humans. Logistic Models. Male. Proto-Oncogene Proteins c-sis. Statistics, Nonparametric

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19581863.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Platelet-Derived Growth Factor; 0 / Proto-Oncogene Proteins c-sis; 0 / platelet-derived growth factor BB
  •  go-up   go-down


86. Lin Y, Qiu JH, Qiao L, He LS, Zha DJ: Le Fort I osteotomy for extensive juvenile nasopharyngeal angiofibroma: a retrospective study. Adv Ther; 2008 Oct;25(10):1057-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Juvenile nasopharyngeal angiofibroma (JNA) is a rare, nonencapsulated, benign neoplasm typically diagnosed in adolescent boys.
  • The optimal surgical procedure should allow maximal exposure of the tumor for complete excision with minimum morbidity.
  • METHODS: We retrospectively studied patients who had undergone JNA resection via the Le Fort I osteotomy approach from July 2000 to September 2007, considering tumor location and size, complications, and tumor recurrence associated with the surgical approach.
  • There were no cases of tumor recurrence that could be attributed to the procedure.
  • [MeSH-major] Angiofibroma / surgery. Nasopharyngeal Neoplasms / surgery. Osteotomy, Le Fort / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18836867.001).
  • [ISSN] 0741-238X
  • [Journal-full-title] Advances in therapy
  • [ISO-abbreviation] Adv Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


87. Boozari B, Lotz J, Galanski M, Gebel M: [Diagnostic imaging of liver tumours. Current status]. Internist (Berl); 2007 Jan;48(1):8, 10-2, 14-6, 18-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic imaging of liver tumours. Current status].
  • These methods have comparable sensitivity and specificity in differentiating a liver lesion as "benign" or "malignant".
  • For benign lesions, CEUS is the recommended method of the choice.
  • If a benign tumor remains unclear, then a needle biopsy is recommended.
  • In the case of a malignant tumor, it is necessary to use a second imaging technique besides CEUS.
  • In addition to the detection and characterization of a liver tumor, CT and MRI provide information on the extrahepatic spread of a tumor, particularly into the lung or retroperitoneum.
  • [MeSH-major] Image Enhancement. Image Processing, Computer-Assisted. Liver Neoplasms / diagnosis. Magnetic Resonance Imaging. Tomography, Spiral Computed. Ultrasonography
  • [MeSH-minor] Contrast Media / administration & dosage. Diagnosis, Differential. Humans. Liver Diseases / diagnosis. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Ultrasound.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Ultrasound Med. 2004 Dec;23 (12 ):1557-68 [15557299.001]
  • [Cites] Ultraschall Med. 2006 Feb;27(1):40-8 [16470478.001]
  • [Cites] Radiology. 1993 Dec;189(3):863-70 [8234717.001]
  • [Cites] Ultraschall Med. 2003 Jun;24(3):175-9 [12817311.001]
  • [Cites] Abdom Imaging. 2004 Sep-Oct;29(5):548-57 [15185025.001]
  • [Cites] Parasitol Int. 2006;55 Suppl:S267-72 [16403670.001]
  • [Cites] Rofo. 2003 Jun;175(6):835-43 [12811698.001]
  • [Cites] Semin Liver Dis. 2004 May;24(2):155-64 [15192788.001]
  • [Cites] Int J Colorectal Dis. 2007 Feb;22(2):201-7 [16733650.001]
  • [Cites] AJR Am J Roentgenol. 2003 Mar;180(3):687-93 [12591675.001]
  • [Cites] AJR Am J Roentgenol. 1981 Feb;136(2):345-8 [6258409.001]
  • [Cites] Ultraschall Med. 2005 Aug;26(4):270-6 [16123920.001]
  • [Cites] Radiology. 2005 Jul;236(1):166-77 [15955857.001]
  • [Cites] Radiology. 2006 Feb;238(2):531-41 [16371577.001]
  • [Cites] Med Princ Pract. 2002 Oct-Dec;11(4):190-5 [12424413.001]
  • [Cites] Clin Radiol. 2003 Aug;58(8):626-9 [12887956.001]
  • [Cites] Eur Radiol. 2006 Oct;16(10):2292-308 [16477402.001]
  • [Cites] Z Gastroenterol. 2005 Oct;43(10):1149-57 [16220456.001]
  • [Cites] AJR Am J Roentgenol. 1995 Dec;165(6):1407-13 [7484575.001]
  • [Cites] Radiographics. 2004 Jan-Feb;24(1):3-17; discussion 18-9 [14730031.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):877-92; discussion 892-4 [11452062.001]
  • [Cites] Am J Surg Pathol. 1999 Dec;23(12):1441-54 [10584697.001]
  • [Cites] Clin Liver Dis. 2001 Feb;5(1):17-42, v [11218914.001]
  • [Cites] J Hepatol. 2001 Sep;35(3):421-30 [11592607.001]
  • [Cites] AJR Am J Roentgenol. 2006 Jan;186(1):158-67 [16357396.001]
  • [Cites] Ann Trop Med Parasitol. 1995 Jun;89(3):261-9 [7668917.001]
  • [Cites] J Clin Gastroenterol. 2005 May-Jun;39(5):401-12 [15815209.001]
  • [Cites] Radiol Clin North Am. 1998 Mar;36(2):319-31 [9520985.001]
  • [Cites] Ultraschall Med. 2004 Dec;25(6):433-7 [15597237.001]
  • [Cites] Z Gastroenterol. 2005 May;43(5):473-5 [15871071.001]
  • [Cites] N Engl J Med. 1999 Oct 28;341(18):1368-78 [10536130.001]
  • [Cites] Z Gastroenterol. 2003 Feb;41(2):191-200 [12650132.001]
  • [Cites] AJR Am J Roentgenol. 2006 Jan;186(1):149-57 [16357395.001]
  • [Cites] AJR Am J Roentgenol. 2006 Jun;186(6):1551-9 [16714643.001]
  • [Cites] Radiology. 2000 Oct;217(1):152-8 [11012438.001]
  • [Cites] Radiology. 2003 Feb;226(2):533-42 [12563151.001]
  • [Cites] Br J Radiol. 2003 Jun;76(906):385-92 [12814924.001]
  • [Cites] Ultraschall Med. 2005 Aug;26(4):277-84 [16123921.001]
  • [Cites] AJR Am J Roentgenol. 2000 Mar;174(3):597-608 [10701595.001]
  • [Cites] Am J Gastroenterol. 2006 Mar;101(3):513-23 [16542288.001]
  • [Cites] J Clin Ultrasound. 1995 Mar-Apr;23 (3):173-8 [7730463.001]
  • [Cites] Ultrasound Med Biol. 2002 Mar;28(3):287-95 [11978408.001]
  • [Cites] Br J Radiol. 2005 Aug;78(932):704-7 [16046421.001]
  • [Cites] Eur Radiol. 2006 Jun;16(6):1337-45 [16453115.001]
  • [Cites] Semin Liver Dis. 2001;21(1):71-80 [11296698.001]
  • [Cites] J Hepatol. 2004 Sep;41(3):421-6 [15336445.001]
  • [Cites] J Comput Assist Tomogr. 2006 May-Jun;30(3):345-54 [16778605.001]
  • [Cites] Radiographics. 2005 Sep-Oct;25(5):1299-320 [16160113.001]
  • [Cites] Hepatology. 2005 Jul;42(1):27-34 [15954118.001]
  • [Cites] AJR Am J Roentgenol. 2006 May;186(5):1401-12 [16632737.001]
  • [Cites] J Chir (Paris). 2001 Feb;138(1):19-26 [11240457.001]
  • [Cites] AJR Am J Roentgenol. 2006 Jun;186(6):1512-9 [16714638.001]
  • [Cites] Liver. 2000 Jul;20(4):312-8 [10959810.001]
  • (PMID = 17216509.001).
  • [ISSN] 0020-9554
  • [Journal-full-title] Der Internist
  • [ISO-abbreviation] Internist (Berl)
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 56
  •  go-up   go-down


88. Fine SW, Epstein JI: Inverted urothelial papillomas with foamy or vacuolated cytoplasm. Hum Pathol; 2006 Dec;37(12):1577-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Inverted papillomas of the bladder are uncommon benign neoplasms characterized by endophytic growth of urothelial cells as anastomosing cords, displaying minimal cytologic atypia.
  • The diagnostic dilemma encountered in these cases of inverted papilloma with foamy or vacuolated cytoplasm warrants their distinction from other benign and malignant urothelial lesions with inverted growth and/or clear cell features.
  • [MeSH-major] Cytoplasm / ultrastructure. Papilloma, Inverted / ultrastructure. Urinary Bladder Neoplasms / ultrastructure. Urothelium / ultrastructure

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16949916.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Abd el-All HS: Breast spindle cell tumours: about eight cases. Diagn Pathol; 2006;1:13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Breast spindle cell tumours: about eight cases.
  • BACKGROUND: Breast spindle cell tumours (BSCTs), although rare, represent a heterogeneous group with different treatment modalities.
  • RESULTS: FNAC defined the tumors as benign (n = 4), suspicious (n = 2) and malignant (n = 3), based on the cytopathological criteria of malignancy.
  • Following wide excision biopsy, the tumors were reclassified into benign (n = 5) and malignant (n = 3).
  • In the benign group, the diagnosis was raised histologically and confirmed by IHC for 3 cases (one spindle cell lipoma, one myofibroblastoma and one leiomyoma).
  • For the remaining two cases, the diagnosis was set up after IHC (one fibromatosis and one spindle cell variant of adenomyoepithelioma).
  • In the malignant group, a leiomyosarcoma was diagnosed histologically, while IHC was crucial to set up the diagnosis of one case of spindle cell carcinoma and one malignant myoepithelioma.
  • The latter technique differentiate benign from malignant BSCTs and is able in 50% of the cases to set up the definite diagnosis.
  • IHC is of value to define the nature of different benign lesions and is mandatory in the malignant ones for optimal treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1987 Jul;11(7):493-502 [3037930.001]
  • [Cites] Cancer. 1988 Oct 15;62(8):1561-7 [2844382.001]
  • [Cites] Eur J Surg Oncol. 1995 Feb;21(1):88-9 [7851564.001]
  • [Cites] Virchows Arch. 1994;425(1):3-24 [7921410.001]
  • [Cites] Virchows Arch. 1994;425(1):89-92 [7921419.001]
  • [Cites] Surg Today. 1996;26(6):449-52 [8782307.001]
  • [Cites] Acta Radiol. 1996 Nov;37(6):893-5 [8995461.001]
  • [Cites] Jpn J Clin Oncol. 1997 Feb;27(1):46-50 [9070341.001]
  • [Cites] Arch Pathol Lab Med. 1997 Jun;121(6):599-603 [9199625.001]
  • [Cites] Pathol Int. 1997 Jun;47(6):404-11 [9211529.001]
  • [Cites] Pathol Res Pract. 1999;195(1):1-10 [10048088.001]
  • [Cites] Pathol Res Pract. 1999;195(4):257-62 [10337665.001]
  • [Cites] Virchows Arch. 1999 Jun;434(6):547-50 [10394891.001]
  • [Cites] Pathology. 1999 Aug;31(3):288-91 [10503279.001]
  • [Cites] J Pathol. 2000 Jul;191(3):282-5 [10878550.001]
  • [Cites] Virchows Arch. 2000 Nov;437(5):540-4 [11147176.001]
  • [Cites] Breast Cancer Res. 2001;3(1):1-4 [11250738.001]
  • [Cites] Australas Radiol. 2001 Feb;45(1):67-70 [11259978.001]
  • [Cites] Diagn Cytopathol. 2001 Jun;24(6):399-402 [11391821.001]
  • [Cites] Pathol Oncol Res. 2001;7(2):151-3 [11458280.001]
  • [Cites] Am J Surg Pathol. 2001 Aug;25(8):1009-16 [11474284.001]
  • [Cites] Pathol Res Pract. 2001;197(7):453-66 [11482575.001]
  • [Cites] Breast J. 2002 Jan-Feb;8(1):55-7 [11856165.001]
  • [Cites] Virchows Arch. 2002 Mar;440(3):249-60 [11889594.001]
  • [Cites] Mod Pathol. 2002 Apr;15(4):397-405 [11950913.001]
  • [Cites] Diagn Cytopathol. 2002 May;26(5):290-3 [11992369.001]
  • [Cites] Breast Cancer. 2002;9(2):175-8 [12016399.001]
  • [Cites] Breast Cancer. 2002;9(2):179-83 [12016400.001]
  • [Cites] Arch Pathol Lab Med. 1996 Nov;120(11):1066-8 [12049111.001]
  • [Cites] Breast J. 2002 Nov-Dec;8(6):383-4 [12390363.001]
  • [Cites] Breast J. 2003 Jul-Aug;9(4):332 [12846874.001]
  • [Cites] Am J Clin Pathol. 2003 Aug;120(2):161-7 [12931544.001]
  • [Cites] Eur J Surg Oncol. 2003 Sep;29(7):600-3 [12943626.001]
  • [Cites] Diagn Cytopathol. 2003 Sep;29(3):172-8 [12951688.001]
  • [Cites] Aust N Z J Surg. 1992 Aug;62(8):628-33 [1322660.001]
  • [Cites] Mod Pathol. 2003 Sep;16(9):893-901 [13679453.001]
  • [Cites] Hum Pathol. 2003 Oct;34(10):1009-15 [14608534.001]
  • [Cites] Surg Today. 2005;35(3):238-42 [15772796.001]
  • [Cites] Am J Surg Pathol. 2006 Mar;30(3):300-9 [16538049.001]
  • [Cites] Eur J Surg. 1991 Feb;157(2):155-8 [1676314.001]
  • [Cites] Am J Surg Pathol. 1991 Jun;15(6):554-68 [1709559.001]
  • [Cites] Acta Cytol. 1991 Jul-Aug;35(4):403-8 [1927173.001]
  • [Cites] Hum Pathol. 1989 Apr;20(4):396-9 [2467872.001]
  • [Cites] Am J Surg Pathol. 1987 Jan;11(1):38-45 [3789257.001]
  • (PMID = 16859566.001).
  • [ISSN] 1746-1596
  • [Journal-full-title] Diagnostic pathology
  • [ISO-abbreviation] Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1557590
  •  go-up   go-down


90. Lokeshwar VB, Cerwinka WH, Isoyama T, Lokeshwar BL: HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Res; 2005 Sep 1;65(17):7782-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
  • However, it is controversial whether hyaluronidase (e.g., HYAL1) functions as a tumor promoter or as a suppressor.
  • Blocking HYAL1 expression inhibited tumor growth by 4- to 7-fold, whereas high HYAL1 producing transfectants either did not form tumors (DU145) or grew 3.5-fold slower (PC-3 ML).
  • Whereas vector and moderate HYAL1 producers generated muscle and blood vessel infiltrating tumors, HYAL1-AS tumors were benign and contained smaller capillaries.
  • Specimens of high HYAL1 producers were 99% free of tumor cells.
  • This study shows that, depending on the concentration, HYAL1 functions as a tumor promoter and as a suppressor and provides a basis for anti-hyaluronidase and high-hyaluronidase treatments for cancer.
  • [MeSH-major] Hyaluronoglucosaminidase / physiology. Prostatic Neoplasms / enzymology
  • [MeSH-minor] Animals. Apoptosis / physiology. Cell Cycle / physiology. Cell Growth Processes / physiology. Cell Line, Tumor. DNA, Antisense / genetics. Humans. Hyaluronic Acid / biosynthesis. Isoenzymes. Male. Mice. Mice, Nude. Neoplasm Transplantation. Neovascularization, Pathologic / enzymology. Transfection. Transplantation, Heterologous

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYALURONIC ACID .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16140946.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / 2R01-CA061038; United States / PHS HHS / / R01 072821-06
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Antisense; 0 / Isoenzymes; 9004-61-9 / Hyaluronic Acid; EC 3.2.1.35 / Hyaluronoglucosaminidase
  •  go-up   go-down


91. Buckner JC, Brown PD, O'Neill BP, Meyer FB, Wetmore CJ, Uhm JH: Central nervous system tumors. Mayo Clin Proc; 2007 Oct;82(10):1271-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Central nervous system tumors.
  • Central nervous system tumors are relatively common in the United States, with more than 40,000 cases annually.
  • Although more than half of these tumors are benign, they can cause substantial morbidity.
  • Malignant primary brain tumors are the leading cause of death from solid tumors in children and the third leading cause of death from cancer in adolescents and adults aged 15 to 34 years.
  • Whereas magnetic resonance imaging helps define the anatomic extent of tumor, biopsy is often required to confirm the diagnosis.
  • Treatment depends on the histologic diagnosis.
  • Benign tumors are usually curable with surgical resection or radiation therapy including stereotactic radiation; however, most patients with malignant brain tumors benefit from chemotherapy either at the time of initial diagnosis or at tumor recurrence.
  • Metastases to the brain remain a frequent and morbid complication of solid tumors but are frequently controlled with surgery or radiation therapy.
  • Unfortunately, the mortality rate from malignant brain tumors remains high, despite initial disease control.
  • This article provides an overview of current diagnostic and treatment approaches for patients with primary and metastatic brain tumors.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Glioma / diagnosis. Glioma / therapy. Humans

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17908533.001).
  • [ISSN] 0025-6196
  • [Journal-full-title] Mayo Clinic proceedings
  • [ISO-abbreviation] Mayo Clin. Proc.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 52
  •  go-up   go-down


92. Rochdi Y, Raji A, Elhattab Y, Nouri H, Bouchoua F, Narjisse Y, Ait Mbark B: [Tuberculosis of the parotid gland]. Rev Laryngol Otol Rhinol (Bord); 2007;128(1-2):121-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] La tuberculose de la glande parotide.
  • INTRODUCTION: Tuberculosis of the parotid gland is a rare entity, and the preoperative diagnosis is difficult as the symptomatology is nonspecific.
  • OBSERVATION: We report a case of a three year old child without a history of tuberculosis, who presented with an isolated parotid mass for three months.
  • Physical examination and ultrasonography suggested a benign tumour.
  • The patient underwent superficial parotidectomy with preservation of the facial nerve, and the diagnosis of tuberculosis was made by histopathological study of the specimen.
  • DISCUSSION-CONCLUSION: This case highlights that tuberculosis of the parotid gland must be kept in mind in the differential diagnosis of parotid swellings, in order to avoid parotidectomy, in a medically treatable condition.

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17633682.001).
  • [ISSN] 0035-1334
  • [Journal-full-title] Revue de laryngologie - otologie - rhinologie
  • [ISO-abbreviation] Rev Laryngol Otol Rhinol (Bord)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


93. Glenn LW: Innovations in neuroimaging of skull base pathology. Otolaryngol Clin North Am; 2005 Aug;38(4):613-29
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CT angiography can assess vascular structures noninvasively, and CT perfusion can help differentiate between malignant and benign tumors.
  • PET scanning and CT/PET scanning will increasingly become a mainstay of head and neck tumor imaging for initial staging, monitoring response to therapy,and detecting recurrent disease or metastases.
  • [MeSH-major] Magnetic Resonance Imaging / methods. Skull Base Neoplasms / diagnosis. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16005721.001).
  • [ISSN] 0030-6665
  • [Journal-full-title] Otolaryngologic clinics of North America
  • [ISO-abbreviation] Otolaryngol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Number-of-references] 16
  •  go-up   go-down


94. Boyce S, Khor YP: A colonic submucosal lipoma presenting with recurrent intestinal obstruction attacks. BMJ Case Rep; 2009;2009
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Colonic submucosal lipomas are rare benign tumours of the colon, which may be discovered incidentally at colonoscopy, through imaging such as CT or at autopsy.
  • These tumours can cause complications such as bleeding, intussusception and bowel obstruction.
  • We describe the case of a patient in whom a small submucosal lipoma was identified at the time of colonoscopy and who did not receive follow-up treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1979 Oct;133(4):743-5 [114027.001]
  • [Cites] Gastrointest Endosc. 1975 Nov;22(2):90-1 [1193347.001]
  • [Cites] Ann Surg. 1958 Nov;148(5):767-72 [13595535.001]
  • [Cites] Gastrointest Endosc. 2003 Sep;58(3):468-70 [14528235.001]
  • [Cites] World J Gastroenterol. 2006 Aug 21;12(31):5075-7 [16937511.001]
  • [Cites] Surg Endosc. 2007 Feb;21(2):265-9 [17122972.001]
  • [Cites] Ulus Travma Acil Cerrahi Derg. 2007 Jul;13(3):227-31 [17978899.001]
  • [Cites] Gastrointest Endosc. 1990 Sep-Oct;36(5):435-8 [2227312.001]
  • [Cites] Gastrointest Endosc. 1997 Nov;46(5):406-11 [9402113.001]
  • [Cites] World J Gastroenterol. 2004 Aug 15;10(16):2444-6 [15285040.001]
  • [Cites] World J Gastroenterol. 2007 Nov 14;13(42):5664-7 [17948945.001]
  • (PMID = 21686420.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3028313
  •  go-up   go-down


95. Ogbureke KU, Nashed MN, Ayoub AF: Huge peripheral osteoma of the mandible: a case report and review of the literature. Pathol Res Pract; 2007;203(3):185-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteomas are rare benign tumors of bone commonly occurring in the maxillofacial skeleton.
  • Here, we report a case of a huge solitary peripheral osteoma of the lingual posterior mandible in a 50-year-old woman who was otherwise in good health.
  • Histological examination confirmed the clinical impression of a peripheral osteoma.
  • [MeSH-major] Mandibular Neoplasms / pathology. Osteoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17307307.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 20
  •  go-up   go-down


96. Bastos Netto JM, Esteves TC, Mattos Rde C, Tibiriçá SH, Costa SM, Vieira LJ: Metanephric adenoma: a rare differential diagnosis of renal tumor in children. J Pediatr Urol; 2007 Aug;3(4):340-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma: a rare differential diagnosis of renal tumor in children.
  • Metanephric adenoma is an extremely rare tumor of the kidney.
  • The clinical and anatomic characteristics are not yet well defined, but it is currently considered to be a benign tumor with a good prognosis, although recently two metastatic cases have been reported.
  • The morphological characteristics are similar to those of Wilms' tumor, suggesting a common embryological precursor.
  • We present here the youngest girl yet to be reported with a diagnosis of metanephric adenoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18947770.001).
  • [ISSN] 1873-4898
  • [Journal-full-title] Journal of pediatric urology
  • [ISO-abbreviation] J Pediatr Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


97. Dong L, Chang XH, Ye X, Zhu LR, Zhao Y, Tian L, Cheng HY, Li XP, Zhang H, Liao QP, Fu TY, Cheng YX, Cui H: [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Zhonghua Fu Chan Ke Za Zhi; 2008 Dec;43(12):931-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
  • OBJECTIVE: To evaluate the value of human epididymis secretory protein 4 (HE4) and CA(125) in the diagnosis of ovarian malignancy.
  • METHODS: HE4 and CA(125) in the serum specimens of malignant ovarian tumor group (30 cases), benign ovarian diseases (110 cases; 45 benign ovarian tumor, 57 endometriotic diseases and 8 pelvic inflammation were included) and healthy women group (137 cases) were assayed double blindly.
  • The levels and the diagnosis efficiency of the HE4 and CA(125) were analyzed. RESULTS:.
  • (1) The median levels of HE4 and CA(125) were significantly higher in malignant ovarian tumor group (244 pmol/L and 601 kU/L respectively) than those of the benign ovarian diseases group (32 pmol/L and 22 kU/L respectively) and healthy women group (32 pmol/L and 11 kU/L respectively) (P = 0.000 - 0.029).
  • The median levels of CA(125) were also higher in endometriotic diseases and pelvic inflammation groups (53 and 41 kU/L respectively) than those of benign ovarian tumor group and healthy women group (12 and 11 kU/L respectively; P = 0.000 - 0.031). (2) The positive rate of HE4 was lower than that of CA(125) in malignant ovarian tumor group (P = 0.036).
  • HE4 was negative in benign diseases and healthy women groups.
  • But the positive rates of CA(125) were 56.1% and 5/8 respectively in endometriotic diseases and pelvic inflammation groups and there were significant differences compared with HE4 (P = 0.000). (3) The HE4 assay had advantage over the CA(125) assay in receiver operating characteristic-area under the curve (ROC-AUC) and sensitivity with a specificity of 100% when ovarian malignancy was compared with controls having benign diseases and healthy women, benign tumor or benign diseases groups respectively.
  • The CA(125) assay had advantage over the HE4 assay in ROC-AUC and sensitivity with the same specificity when ovarian cancers were compared with controls having healthy women group. (4) Combined assay of HE4 and CA(125) was better than CA(125) alone when ovarian malignancy was compared with controls having any group. (5) Combined assay was better than HE4 alone in ROC-AUC and sensitivity with the same specificity when ovarian cancers were compared with controls having benign diseases and healthy women or healthy women groups.
  • And combined assay was lower in the ROC-AUC and the sensitivity with specificity of 100% than HE4 when ovarian cancers were compared with controls having benign tumors or benign diseases groups respectively. (6) The diagnosis efficiency of the HE4 assay at the level 86 pmol/L determined in ROC curve with controls having benign diseases and healthy women group and at the 95% reference level 50 pmol/L of healthy women or 150 pmol/L recommended by the kit respectively was compared.
  • The set point of 86 pmol/L had advantage over 150 pmol/L at the sensitivity of diagnosis, 70% and 63% respectively.
  • CONCLUSIONS: The specificity of HE4 assay is higher than CA(125) assay in the diagnosis of ovarian cancer and HE4 combined with CA(125) assay can improve the diagnoses.
  • The set point of 150 pmol/L is advantageous for the accurate diagnosis, while the set point of 86 pmol/L is advantageous for the screening of malignant ovarian cancer.
  • [MeSH-major] Biomarkers, Tumor / blood. CA-125 Antigen / blood. Epididymal Secretory Proteins / analysis. Ovarian Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Area Under Curve. Case-Control Studies. Double-Blind Method. Endometriosis / blood. Enzyme-Linked Immunosorbent Assay. Female. Humans. Middle Aged. Pelvic Neoplasms / blood. ROC Curve. Sensitivity and Specificity. Young Adult. beta-Defensins

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19134334.001).
  • [ISSN] 0529-567X
  • [Journal-full-title] Zhonghua fu chan ke za zhi
  • [ISO-abbreviation] Zhonghua Fu Chan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CA-125 Antigen; 0 / DEFB126 protein, human; 0 / Epididymal Secretory Proteins; 0 / beta-Defensins
  •  go-up   go-down


98. Rushing EJ, Cooper PB, Quezado M, Begnami M, Crespo A, Smirniotopoulos JG, Ecklund J, Olsen C, Santi M: Subependymoma revisited: clinicopathological evaluation of 83 cases. J Neurooncol; 2007 Dec;85(3):297-305
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECT: Subependymomas are rare ependymal neoplasms.
  • To date, a large clinicopathologic study of these benign neoplasms treated with modern neurosurgical techniques has not been reported.
  • Tumors arose in the posterior fossa (n = 43), lateral ventricles (n = 37), spinal cord (2) and only one arose in the temporal horn.
  • Tumors ranged in size from 2.0 mm to 60 mm in greatest dimension (mean, 23.0 mm).
  • Eighteen-percent (15/83) of subependymomas exhibited a mixed histologic pattern; that is, subependymoma together with another glial tumor.
  • All patients were without evidence of disease at the last follow-up: alive (n = 28) or dead (n = 8).
  • [MeSH-major] Cerebral Ventricle Neoplasms / pathology. Ependymoma / pathology. Glioma, Subependymal / pathology. Infratentorial Neoplasms / pathology. Mixed Tumor, Malignant / pathology

  • Genetic Alliance. consumer health - Subependymoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJNR Am J Neuroradiol. 1995 Nov-Dec;16(10):2121-9 [8585504.001]
  • [Cites] J Comput Assist Tomogr. 1995 Jul-Aug;19(4):518-26 [7622676.001]
  • [Cites] AJR Am J Roentgenol. 1995 Nov;165(5):1245-50 [7572512.001]
  • [Cites] J Neurosurg. 1994 Jun;80(6):1108-11 [8189269.001]
  • [Cites] Mod Pathol. 2004 Mar;17(3):227-87 [14752523.001]
  • [Cites] J Neurosurg. 1983 Dec;59(6):1088-91 [6631507.001]
  • [Cites] Neurosurgery. 2006 May;58(5):881-90; discussion 881-90 [16639322.001]
  • [Cites] Arch Pathol Lab Med. 1999 Apr;123(4):306-9 [10320142.001]
  • [Cites] J Neurooncol. 2005 Mar;72(1):25-8 [15803371.001]
  • [Cites] Mod Pathol. 2005 Jul;18(7):991-7 [15731777.001]
  • [Cites] J Neurosurg. 1991 Oct;75(4):583-8 [1885976.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Jan 1;108(1):84 [9973931.001]
  • [Cites] AJNR Am J Neuroradiol. 1990 Jan-Feb;11(1):83-91 [2105621.001]
  • [Cites] Pathol Int. 2003 Mar;53(3):169-73 [12608898.001]
  • [Cites] Am J Pathol. 1999 Aug;155(2):627-32 [10433955.001]
  • [Cites] Neurosurgery. 1992 Oct;31(4):741-5 [1407461.001]
  • [Cites] J Neurooncol. 2003 Jan;61(1):57-67 [12587796.001]
  • [Cites] Arch Pathol Lab Med. 1999 Oct;123(10):873 [10506435.001]
  • [Cites] J Neurosurg. 1998 Mar;88(3):496-505 [9488304.001]
  • [Cites] J Neurosurg. 1978 Nov;49(5):689-96 [712391.001]
  • [Cites] Neurosurgery. 1986 Oct;19(4):594-8 [3785597.001]
  • [Cites] Clin Neurol Neurosurg. 1997 Feb;99(1):17-22 [9107462.001]
  • [Cites] AJNR Am J Neuroradiol. 1990 May;11(3):567-74 [2349896.001]
  • [Cites] J Neurosurg. 1985 Apr;62(4):508-12 [3973720.001]
  • (PMID = 17569000.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z: Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer; 2009;9:40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased PADI4 expression in blood and tissues of patients with malignant tumors.
  • METHODS: Expression of PADI4 was investigated in various tumors and non-tumor tissues (n = 1673) as well as in A549, SKOV3 and U937 tumor cell lines by immunohistochemistry, real-time PCR, and western blot.
  • Levels of PADI4 and citrullinated antithrombin (cAT) were investigated in the blood of patients with various tumors by ELISA (n = 1121).
  • However, PADI4 expression was not observed in benign leiomyomas of stomach, uterine myomas, endometrial hyperplasias, cervical polyps, teratomas, hydatidiform moles, trophoblastic cell hyperplasias, hyroid adenomas, hemangiomas, lymph hyperplasias, schwannomas, neurofibromas, lipomas, and cavernous hemangiomas of the liver.
  • Additionally, PADI4 expression was not detected in non-tumor tissues including cholecystitis, cervicitis and synovitis of osteoarthritis, except in certain acutely inflamed tissues such as in gastritis and appendicitis.
  • Quantitative PCR and western blot analysis showed higher PADI4 expression in gastric adenocarcinomas, lung adenocarcinomas, hepatocellular carcinomas, esophageal squamous cell cancers and breast cancers (n = 5 for each disease) than in the surrounding healthy tissues.
  • Furthermore, western blot analysis detected PADI4 expression in cultured tumor cell lines.
  • ELISA detected increased PADI4 and cAT levels in the blood of patients with various malignant tumors compared to those in patients with chronic inflammation and benign tumors.
  • Additionally, PADI4 and cAT levels were significantly associated with higher levels of known tumor markers.
  • CONCLUSION: Our results suggest that PADI4 expression is increased in the blood and tissues of many malignant tumors, a finding useful for further understanding of tumorigenesis.
  • [MeSH-major] Hydrolases / metabolism. Neoplasm Proteins / metabolism. Neoplasms / metabolism
  • [MeSH-minor] Antithrombins / metabolism. Blotting, Western. Cell Line, Tumor. Citrulline / metabolism. Enzyme-Linked Immunosorbent Assay. Female. Humans. Immunohistochemistry. Immunoprecipitation. Male. Polymerase Chain Reaction / methods

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Tumori. 1998 May-Jun;84(3):364-7 [9678618.001]
  • [Cites] Pathologe. 1996 Nov;17(6):425-32 [9082363.001]
  • [Cites] J Cell Mol Med. 2004 Oct-Dec;8(4):498-508 [15601578.001]
  • [Cites] Folia Histochem Cytobiol. 2004;42(4):235-40 [15704650.001]
  • [Cites] Rheumatology (Oxford). 2005 Mar;44(3):293-8 [15561738.001]
  • [Cites] Semin Cancer Biol. 2005 Aug;15(4):309-18 [15907383.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2936-42 [16365013.001]
  • [Cites] Mol Carcinog. 2006 Mar;45(3):183-96 [16355400.001]
  • [Cites] Mod Pathol. 2006 Sep;19(9):1261-9 [16799479.001]
  • [Cites] Mol Endocrinol. 2007 Jul;21(7):1617-29 [17456793.001]
  • [Cites] J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):76-80 [17826626.001]
  • [Cites] World J Gastroenterol. 2008 Mar 21;14(11):1682-9 [18350599.001]
  • [Cites] Histochem Cell Biol. 2008 Jun;129(6):705-33 [18461349.001]
  • [Cites] Endocr Relat Cancer. 2008 Jun;15(2):475-83 [18509000.001]
  • [Cites] J Biol Chem. 2008 Jul 18;283(29):20060-8 [18499678.001]
  • [Cites] Mol Cell Biol. 2008 Aug;28(15):4745-58 [18505818.001]
  • [Cites] Adv Exp Med Biol. 2008;630:112-32 [18637488.001]
  • [Cites] Histopathology. 2001 Jan;38(1):62-7 [11135048.001]
  • [Cites] Cell Death Differ. 2002 May;9(5):486-92 [11973607.001]
  • [Cites] Biochem Soc Trans. 2002 Apr;30(2):173-7 [12023846.001]
  • [Cites] Biochem Soc Trans. 2002 Apr;30(2):201-7 [12023851.001]
  • [Cites] Nat Genet. 2003 Aug;34(4):395-402 [12833157.001]
  • [Cites] Best Pract Res Clin Anaesthesiol. 2004 Sep;18(3):385-405 [15212335.001]
  • [Cites] Cell. 2004 Sep 3;118(5):545-53 [15339660.001]
  • [Cites] Anticancer Res. 1990 May-Jun;10(3):579-82 [2114816.001]
  • [Cites] APMIS. 1991 Nov;99(11):981-8 [1720319.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1992;421(3):209-15 [1384221.001]
  • [Cites] Int J Cancer. 1993 Jul 9;54(5):793-806 [7686887.001]
  • [Cites] Thromb Haemost. 1998 Nov;80(5):767-72 [9843169.001]
  • (PMID = 19183436.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antithrombins; 0 / Neoplasm Proteins; 29VT07BGDA / Citrulline; EC 3.- / Hydrolases; EC 3.5.3.15 / peptidylarginine deiminase type IV
  • [Other-IDs] NLM/ PMC2637889
  •  go-up   go-down


100. Ge D, You Z: Expression of interleukin-17RC protein in normal human tissues. Int Arch Med; 2008;1(1):19
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: IL-17RC expression in 51 normal human tissues and two benign tumors (i.e., lymphangioma and parathyroid adenoma) on the tissue microarrays was determined by immunohistochemical staining, using two polyclonal antibodies against IL-17RC.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2078-87 [18310510.001]
  • [Cites] J Invest Dermatol. 2008 May;128(5):1207-11 [18200064.001]
  • [Cites] Cytokine. 2008 Feb;41(2):92-104 [18178098.001]
  • [Cites] Cytokine. 2008 Feb;41(2):105-13 [18061473.001]
  • [Cites] Cytokine. 2008 Feb;41(2):84-91 [18039580.001]
  • [Cites] J Clin Invest. 2008 Feb;118(2):597-607 [18202747.001]
  • [Cites] Nat Immunol. 2008 Feb;9(2):124-6 [18204425.001]
  • [Cites] J Immunol. 2008 Jan 1;180(1):655-63 [18097068.001]
  • [Cites] Cytokine. 2007 Oct;40(1):35-43 [17881243.001]
  • [Cites] J Immunol. 2007 Oct 15;179(8):5462-73 [17911633.001]
  • [Cites] Cytokine. 2007 Jun;38(3):157-64 [17644350.001]
  • [Cites] J Heart Lung Transplant. 2007 Jul;26(7):669-74 [17613395.001]
  • [Cites] Neoplasia. 2007 Jun;9(6):464-70 [17603628.001]
  • [Cites] Cell Res. 2007 May;17(5):435-40 [17452998.001]
  • [Cites] J Biol Chem. 2007 May 4;282(18):13447-55 [17355969.001]
  • [Cites] J Immunol. 2007 Apr 1;178(7):4466-72 [17372004.001]
  • [Cites] J Neuroimmunol. 2007 Feb;183(1-2):96-103 [17240458.001]
  • [Cites] J Immunol. 2007 Feb 1;178(3):1372-8 [17237384.001]
  • [Cites] J Immunol. 2006 Dec 15;177(12):8542-9 [17142752.001]
  • [Cites] J Immunol. 2006 Nov 15;177(10):6852-8 [17082599.001]
  • [Cites] Prostate. 2006 Sep 1;66(12):1268-74 [16688746.001]
  • [Cites] J Neurosci Res. 2006 Aug 1;84(2):379-88 [16676327.001]
  • [Cites] J Immunol. 2006 Jul 1;177(1):566-73 [16785554.001]
  • [Cites] J Immunol. 2006 Jul 1;177(1):36-9 [16785495.001]
  • [Cites] J Exp Med. 2006 Jul 10;203(7):1685-91 [16818675.001]
  • [Cites] Cell Signal. 2006 Aug;18(8):1287-98 [16310341.001]
  • [Cites] Cell Immunol. 2005 Oct;237(2):123-30 [16386239.001]
  • [Cites] Cancer Res. 2006 Jan 1;66(1):175-83 [16397230.001]
  • [Cites] J Immunol. 2006 Jan 15;176(2):711-5 [16393951.001]
  • [Cites] Nat Immunol. 2005 Nov;6(11):1123-32 [16200070.001]
  • [Cites] Nat Immunol. 2005 Nov;6(11):1133-41 [16200068.001]
  • [Cites] J Immunol. 2005 Nov 1;175(9):6177-89 [16237115.001]
  • [Cites] Am J Respir Cell Mol Biol. 2005 Sep;33(3):248-53 [15901616.001]
  • [Cites] J Immunol. 2005 Jul 1;175(1):404-12 [15972674.001]
  • [Cites] J Cell Physiol. 2005 Aug;204(2):560-6 [15799031.001]
  • [Cites] Immunity. 2005 Mar;22(3):285-94 [15780986.001]
  • [Cites] J Exp Med. 2005 Jan 17;201(2):233-40 [15657292.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Jan 21;326(3):624-31 [15596145.001]
  • [Cites] Cancer Res. 2004 Nov 15;64(22):8276-84 [15548695.001]
  • [Cites] Cancer Res. 1999 Aug 1;59(15):3698-704 [10446984.001]
  • [Cites] J Immunol. 1999 Jan 1;162(1):577-84 [9886435.001]
  • [Cites] J Immunol. 1995 Dec 15;155(12):5483-6 [7499828.001]
  • [Cites] Immunity. 1995 Dec;3(6):811-21 [8777726.001]
  • [Cites] Immunity. 2004 Oct;21(4):467-76 [15485625.001]
  • [Cites] Joint Bone Spine. 2004 Mar;71(2):87-90 [15050191.001]
  • [Cites] Cell Mol Life Sci. 2004 Mar;61(5):567-79 [15004696.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1229-34 [14742870.001]
  • [Cites] J Biol Chem. 2003 Dec 12;278(50):50273-82 [12958313.001]
  • [Cites] Br J Pharmacol. 2003 Oct;140(4):595-610 [14504135.001]
  • [Cites] J Biol Chem. 2003 Aug 29;278(35):33232-8 [12807873.001]
  • [Cites] Prostate. 2003 Aug 1;56(3):171-82 [12772186.001]
  • [Cites] Scand J Gastroenterol. 2003 Feb;38(2):180-5 [12678335.001]
  • [Cites] Cytokine Growth Factor Rev. 2003 Apr;14(2):155-74 [12651226.001]
  • [Cites] Gut. 2003 Jan;52(1):65-70 [12477762.001]
  • [Cites] Nat Med. 2002 May;8(5):500-8 [11984595.001]
  • [Cites] J Biol Chem. 2002 Feb 8;277(6):4309-16 [11706037.001]
  • [Cites] Nat Cell Biol. 2002 Feb;4(2):170-4 [11802165.001]
  • [Cites] Nat Cell Biol. 2002 Feb;4(2):165-9 [11802164.001]
  • [Cites] J Immunol. 2002 Jan 15;168(2):861-8 [11777983.001]
  • [Cites] J Immunol. 2001 Nov 15;167(10):6015-20 [11698482.001]
  • [Cites] Transplant Proc. 2000 Nov;32(7):1773 [11119928.001]
  • [Cites] J Biol Chem. 2001 Jan 12;276(2):1660-4 [11058597.001]
  • [Cites] J Biol Chem. 2000 Jun 23;275(25):19167-76 [10749887.001]
  • [Cites] J Immunol. 2008 Aug 15;181(4):2799-805 [18684971.001]
  • [Cites] J Exp Med. 2008 May 12;205(5):1063-75 [18411338.001]
  • (PMID = 18928529.001).
  • [ISSN] 1755-7682
  • [Journal-full-title] International archives of medicine
  • [ISO-abbreviation] Int Arch Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2596096
  •  go-up   go-down






Advertisement